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The purpose of the EPIP project is to address uncontrolled diabetes by implementing an 
evidence-based shared medical appointment (SMA) intervention which based on the body of the 
evidence will help improve diabetes outcomes. A pilot implementation and retrospective chart 
review were conducted. Data was collected on outcome indicators such as blood pressure, lipid 
values, body mass index, A1C, and knowledge. The results of a pilot SMA implementation 
revealed that patients who participated in the weekly SMA saw an improvement in post-mean 
values compared to pre-mean values. Mean A1c dropped to 7.0% from 7.11%; systolic blood 
pressure improved to125 mmHg from 128 mmHg; diastolic blood pressure dropped to 77 mmHg 
from 84 mmHg; body mass index dropped to 33.63 kg/m2 from 35.44 kg/m2; and, knowledge 
increased from 52% to 93%.  Retrospective chart review findings revealed that the number of 
patients who were at goal A1C increased from 25% to 38% post intervention. The number of 
patients at goal for hypertension increased from 65% to 88%, and mean HbA1c dropped from 
8.0% to 7.5%. These findings are consistent with those represented in the body of the evidence, 
suggesting SMA as an effective and feasible intervention to helping diabetes patients to meet 
glycemic goals and improving diabetes outcomes. Therefore, policy and culture change are 
 vi 
 
warranted to adopt and sustain SMA as the standard of diabetes care. New clinic policies, SMA 
clinic mentors, and utilization of conceptual models will promote sustainability of SMA.  
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Chapter 1 
Development of Clinical Question and Problem Identification (EBP Steps 0, 1, & 2) 
Background and Significance  
Diabetes is currently affecting 422 million people globally; this is a rise of 314 million 
people since 1980 (World Health Organization (WHO), 2018). The global prevalence of diabetes 
among adults over the age of 18 years has risen from 4.7% in 1980 to 8.5% in 2014 (WHO, 
2018). The prevalence has been rising more rapidly in middle and low-income countries (WHO, 
2018). In the United States (US), diabetes is currently affecting 30.3 million Americans or 9.4% 
of the US population; out of this number, 23.1 million have been diagnosed and 7.2 million have 
the disease but are yet to be diagnosed (Centers for Disease Control and Prevention (CDC), 
2017).  
Some of the common and serious complications of diabetes include cardiovascular and 
chronic kidney diseases. In 2014, a total of 7.2 million hospital discharges with diabetes as the 
diagnosis were reported in the US; out of these number, 1.5 million discharges were due to major 
cardiovascular events with 400,000 reported as ischemic heart disease, and 251,000 reported as 
stroke (CDC, 2017). Moreover, in 2014, 52,159 people developed end-stage renal disease with 
diabetes as the primary cause (CDC, 2017). Diabetes not only affects patients physically, but 
also economically affects individuals and taxpayers as whole. In 2017, the total cost of diabetes 
in the United States (US) was estimated to be $327 billion, with $237 billion related to direct 
medical costs, and $90 billion related to reduce productivity (American Diabetes Association 
(ADA), 2018). Average medical expenditures among people with diabetes is 2.3 times higher 
than people without diabetes (ADA, 2018). Furthermore, according to CDC (2017), 84.1 million 
people age 18 years and older, or 33.9% of US population have prediabetes. 
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Prediabetes is a condition whereby blood sugar levels are higher than normal but are less 
than the values required to diagnose diabetes. According to ADA (2018), normal Glycosylated 
hemoglobin A1c (HbA1c) is less than 5.7%, and for prediabetes an acceptable A1C is between 
5.7% and 6.4%. For a patient to be diagnosed with diabetes, their A1C must be 6.5% or greater. 
Having prediabetes increasingly puts an individual at risk for developing type II diabetes, 
especially in the presence of strong family history, lack of physical activity, and poor diet. 
Adoption of meaningful life style modifications such as losing weight, moderate intensity 
physical activity and healthy diet, can reduce the risk of prediabetes progressing to full diabetes 
by as much as 58 % (CDC, 2017).  
In my previous practice, approximately 90% of my patients have one or two diagnoses of 
mental illness. Thus, an additional diagnosis of diabetes becomes very challenging for both the 
patient and the provider because certain antipsychotic drugs can exacerbate blood sugars. These 
patients also because of their multiple co-morbidities have difficulties following through with 
their follow up appointments and recommended life style modification.  Approximately 15% of 
my patients at the time have type II diabetes. The average HbA1c in the clinic was 7.4%, and 
approximately 20% of the patients who have diabetes are either overweight or obese. The 
average body mass index (BMI) at the clinic was 36, while normal BMI is below 25kg/m^2. 
There is a clear need for better management of diabetes within this patient population.  
Patient education and their involvement in care is an important part of the overall management of 
diabetes to prevent complications. One of the emerging and innovative ways to accomplish this 
is through shared medical appointment (SMA), also known as group visits. During SMA visit, a 
medical provider attends to each patient for 3-10 minutes in a group setting, eliciting 
conversation and discussion of patient’s medical problems with the group for a longer period so 
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that assessment becomes part of the education, and patient to patient interaction becomes a 
learning opportunity. A discussion among patients elicits positive health behavior change 
including: medication management, education about diabetes, self-management strategies 
including diet, exercise, and losing weight (Heyworth et al., 2014). Constructive patient 
interactions are encouraged during SMA sessions. Interactions such as patients sharing success 
stories with each other to motivate others who are not doing well in their management are 
encouraged. Efficient and effective peer support is central to group sessions (Edelman at al., 
2014). SMA creates a supportive group environment where ideas and solutions are shared by 
patients. The use of group as a treatment modality is rooted from social learning theory that 
states that people learn new information from one another by watching other people and 
imitating the behavior of others (Caballero, 2015).   
In contrast, individual medical appointment (IMA) is when a patient sees a provider alone 
in an exam room and the assessment and education takes place at that time in a typically short 
visit. There is usually no patient to patient interaction and discussion of experiences (Watts et al., 
2015). The question now is which of these encounter modalities works best for patients with 
diabetes.   
PICOT Question 
Therefore, the clinical question that arises is “In diabetic patients(P), how does shared 
medical appointments(I) compared with individual medical appointments(C) affect hemoglobin 
A1c results and BMI(O) in 3 months(T)?”   
Systematic Search 
To answer the PICOT question, a systematic search was conducted within the following 
databases: Cumulative Index Nursing and Allied Health Literature (CINAHL), PubMed, and 
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Cochrane database for systematic reviews (CDSR). The keywords from the PICOT question 
were identified as “shared medical appointment,” “diabetes,” “hemoglobin A1c,” “individual 
appointments” “mental health” and “body mass index”. Additionally, “Group visits” and “usual 
care” were keywords identified during the searches. The search to find answers to clinical 
question began with CINAHL.  The individual keywords were searched initially, and the results 
were saved in search history. Then different combinations of the keywords searched, yielding 19 
citations. PubMed was searched with the same keywords and search strategy. Individual 
keywords were searched initially and added to search history. Different hits obtained with this 
strategy, then different keyword combinations were used, yielding 11 final citations. Lastly, 
Cochrane Database for Systematic reviews (CDSR) was searched with the same keywords and 
search strategy.  Keyword combinations were used as in CINAHL and PubMed, first “group 
visits” with “hemoglobin A1C” and the yield was 6 citations.  Then “shared medical 
appointments” and “diabetes” were searched, which yielded 12 citations. 
The combined search results from the 3 data bases were reviewed for title. During this 
process, out of the 42 total articles that were reviewed, 22 articles were excluded because either 
the tittle was not relevant to the topic or SMA intervention was not done in diabetes. A total of 
20 articles were selected for abstract review, and 3 additional articles were excluded after the 
review because of duplication. A total of 17 studies were selected for full review.  Two of the 17 
studies were only study protocols without the results and were therefore excluded. This left a 
total of 15 studies for critical appraisal (See appendix A, figure 1.0) 
Selection of Evidence Based Practice (EBP) Model  
The EBP model that guided the intervention was the Model for Evidence Based Practice 
Change. This model is a revised version of the model by Rosswurm and Larrabee (1999). The 
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revised steps and the schematic diagram were prompted by Larrabee’s experience with educating 
and guiding nurses in the application of the original model since 1999 at West Virginia 
University Hospitals (See appendix F, figure 1.1) (Dang et al., 2015). 
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Chapter 2 
Critical Appraisal of Evidence, Model of EBP & EPIP Plan: Part 1(EBP Process Steps 1, 
2, 3, & 4) 
Body of the Evidence 
To find answers to the proposed clinical question, 15 quantitative studies were identified 
and reviewed using rapid critical appraisal. The studies used various methodologies. After the 
general appraisal overview (GAO) and rapid critical analysis (RCA), it was determined that all 
the 15 studies reviewed will be relevant to the evidence synthesis. After identifying the keeper 
studies, the information from GAO forms and RCA checklists was transferred to an evaluation 
table to make appraisal easier across the studies (See appendix B, table A). 
Hierarchy of evidence provides guidance during evidence review to determine which 
evidence is likely to provide the most reliable answers to the clinical question. Out of the 15 
studies reviewed, two were level I evidence, five were level II evidence, six were level III 
evidence, one was level IV evidence, none were level VI evidence, and one was level VII 
evidence (See appendix C, table B). Level I evidence is comprised of systematic review of 
randomized control trials, and they are the strongest evidence (Melnyk, Morrison-Beedy, & 
Cole, 2015).  
 Two out of the 15 studies reviewed were level I evidence. Edelman et al. (2014) and 
Housden et al. (2013) conducted systematic reviews to evaluate the effectiveness of the SMA in 
reducing HbA1c levels in patients with poor blood sugar control. Both studies included in their 
review randomized control trial (RCT) and observational studies. The studies included in 
Edelman et al. (2014) study were 13 RCT and four observational studies, with a total of 17 
studies reviewed (See appendix B, table A). Housden et al. (2013) included 26 studies in their 
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review, out of which 13 studies were RCT (Appendix B, table A). Out of the 13 RCTs which 
both studies reviewed, 10 were duplicates and the other three studies were different. One study 
utilized meta-analysis, while the other study was systematic review only.  Both studies measured 
hemoglobin A1c as an outcome, and the results improved in both studies among those who 
attended SMA. Edelman et al. (2014) also measured lipid values and blood pressure, which all 
improved from baseline (See Appendix C, Table C). Both studies concluded that SMA was 
effective in reducing hemoglobin A1c levels. Moreover, Edelman et al. (2014) additionally 
concluded that SMA was effective in reducing lipid values and blood pressure as well. 
Therefore, since level I evidence is considered the highest level of evidence in evidence 
hierarchy, and based on the conclusion of the two studies, SMA should be recommend as the 
standard of care in managing diabetic patients to improve outcomes. 
Randomized control trials are considered level II evidence and are the strongest design to 
test for cause and effect. They usually provide reliable evidence that can be used to make 
decisions regarding EBP (Melynk, Morrison-Beedy, & Cole, 2015).  Out of the five RCTs 
reviewed, one conducted SMA every month, two studies monthly, and two studies four times 
weekly followed by five monthly SMA booster sessions. The duration of the studies varied, two 
studies conducted SMA lasting 1.5 hours per session, two lasted for two hours per session and 
one did not mention the duration of the SMA per session. The total duration of the SMA was as 
follows: one lasted for 12 months, two lasted for six months, one lasted for three months and one 
lasted for 15 months (See Appendix C, Table D). The curriculum of the SMA education was 
very similar across the studies. Four out of the five RCTs reviewed included medication 
management, all the five studies included nutrition, three included exercises, three included 
behavior counseling, four included diabetes overviews, and three included foot care (See 
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Appendix C, Table E). For SMA logistics, five out of five studies included medical management, 
group support, Diabetes Self-Management Education (DSME), a nurse, and a medical provider. 
Two studies included 4-6 patients per group session, one study included 6-8 patients per group 
sessions, and one study included 20-25 patients. Out of five studies, two included dietician, one 
included exercise trainer, and one included counselor (See Appendix C, table F). For the 
outcome measures across the studies, four out of the five studies measured hemoglobin A1c and 
the values decreased compared to baseline. Three studies measured lipid values and all of them 
indicated improved values. Five studies measured blood pressure and all five reported decrease 
in blood pressure. One study measured weight, and reported decrease compared to baseline value 
(See appendix C, table C). The studies concluded that SMA was effective in improving 
hemoglobin A1c values, blood pressure, lipid values, and weight. These findings agree with 
higher level 1 studies.  Therefore, SMA should be recommend as the standard of care to improve 
diabetes outcomes 
Quasi-experimental designs are considered as Level III evidence and are experimental 
studies without randomization to the intervention and control groups. This kind of design is 
commonly used when randomization is not feasible.  These designs are weaker than RCT (O’ 
Mathuna & Fineout-Overholt, 2015). Out of the six level III studies that were reviewed, five 
measured hemoglobin A1c, three measured lipid values, three measured blood pressure, three 
measured weight, and one measured knowledge as the outcomes of the intervention. Out of all 
the five studies that measured hemoglobin A1c as the outcome of the intervention, the results 
improved in each one of them compared to baseline values. The three out of the six studies that 
measured lipid values, the results improved in two studies, and values reduced in one study, but 
it was not statistically significant. The three out of the six studies that measured blood pressure 
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reported improvement in the numbers. Out of the six studies, three that measured weight reported 
a reduction, but one study reported none statistically significant reduction. Lastly, one study 
measured knowledge, and the results indicated increased in the outcome (See appendix C, table 
C). Out of the six studies reviewed, one conducted SMA monthly, two weekly, one biweekly, 
and one weekly four times, then two bi monthly booster SMA sessions. Out of the six studies, 
two studies lasted for two hours per SMA session, two lasted for three hours, and one lasted for 
1.5 hours. For the total duration of the studies, one lasted for a total of three months, one lasted 
for three weeks, one lasted for four weeks, one lasted for eight weeks, and one lasted for five 
months (See appendix C, table D). For the SMA education curriculum, four out of the six studies 
included medication management, four included nutrition, four included exercise, four included 
behavioral modification teaching, four included diabetes foot care, and two included diabetes 
overview education (See appendix C, table E). For SMA logistics across the studies, six out of 
six studies reviewed incorporated medical management in the SMA, six out six included peer 
support, six out six included DSME, one study utilized 4-20 patients per group session, 1 utilized 
11 patients per group, and 1 utilized 4-6 patients per group, six out of six studies included a 
medical provider, three out six studies included a nurse, two included a dietician, and 1 included 
a counselor (See appendix C, table F). The studies concluded that SMA was effective in 
improving hemoglobin A1C values, blood pressure, lipid values and increased patient 
knowledge. This conclusion agrees with the findings of higher level 1 and II studies.  Therefore, 
SMA should be recommended as the standard of the care in managing diabetes patients. 
Cohort designs are considered level IV evidence. In this study design, the researchers 
follow a group of people who are exposed to a condition to see if they will develop an outcome 
of interest. The researchers follow patients for a long time, and as a result the study is usually 
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considered as a longitudinal study (Melnyk, Morrions-Beedy, & Cole, 2015). This was the only 
cohort study out of the 15 studies reviewed. The study measured hemoglobin A1c as the only 
outcome and the results improved (See appendix C, table C).  The SMA duration per session was 
1.5 hours and the total duration of the intervention lasted for 12 months (See appendix C, table 
D). The study included in the SMA education plan includes medication management, nutrition, 
exercise, behavior modification, and diabetes overview (See appendix C, table E). The study 
logistics included medical management of patients during the visit, peer support, DSME, the 
study utilized 8-15 patients per session, the study included a nurse, a medical provider, and a 
health psychologist (See appendix C, table F). The study concluded that SMA was effective in 
improving hemoglobin A1c values. This level IV study findings agrees with higher level 1, II, 
and III studies.  Therefore, SMA should be recommended as the standard of care in managing 
diabetes patients.  
Finally, Ridge (2012) conducted a literature review regarding SMA. The review included 
different research designs, including randomized control trials and non- randomized control 
trials. Literature reviews are considered as lower tier evidence, and therefore, their findings 
cannot be solely used to base practice change.  However, the results of this review concluded that 
SMA can be effective in improving hemoglobin A1c, knowledge, and quality of life in patients 
with diabetes, which agrees with higher tier levels of evidence. (See appendix B, table A).     
Based on the evidence from the studies, diabetes self-management skill education must 
be included in any SMA intervention. This topic was common across all the studies reviewed 
(See appendix C, table E). This is an important component of the SMA intervention. Studies 
have found that patients are likely to participate in their own care if they have a better 
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understanding of their disease process and self- care measures (Caballero, 2015). Therefore, 
diabetes self-management should be integrated in all SMA interventions. 
After an exhaustive and systematic search of the literature to help gather evidence to 
answer the clinical question, an evaluation table was created from which a synthesis table was 
also created outlining the current state of the evidence regarding SMA. Creation of the synthesis 
table helped bring clarity to the current state of the evidence and its practice worth. After a 
thorough review of the synthesis table, it is now very clear that SMA is effective in reducing 
hemoglobin A1c and helps patients meet their hemoglobin A1c goal of less than 7. Out of the 15 
quantitative studies that were reviewed, 13 measured hemoglobin A1c as the primary outcome of 
the intervention, and all 13 studies found that SMA was effective in reducing A1c (See appendix 
C, table C). The conclusions from several studies comparing IMA to SMA supported that SMA 
is more effective.  
Recommendation from Evidence Synthesis  
SMA should be recommend as the standard of care for diabetes management, and each 
SMA session should include: DSME, medical management, and peer support as recommended in 
the body of the evidence.  
Ethics and EBP 
The ethics of EBP implementation involves planning a protocol that is in conformity with 
all the ethical standards. During the project protocol planning, all the ethical standards were 
observed, and all the interventions planned in way that contributed to the improvement of patient 
care and not put patients at risk. Unlike research methods, there is no inclusion or exclusion 
criteria for EBP implementation. It is unethical to include some patients in receiving best 
practice while excluding others. Best practices should be offered to all patients and it is up to the 
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patients to either participate or refused. If patients refused, they should not be coerced or forced 
to participate thereby violating their autonomy. SMA intervention was offered to all the diabetic 
patients in the clinic. The planning of the project involved designing of a logic model (See 
appendix H, figure 1.3). This planning included outlining the activities of the project such as 
process makers.  
 Clinicians should always provide care to their patients using evidence that has been 
vigorously vetted. Using evidence in clinical practice that is unvetted, is not only unethical, but it 
will not produce desired results. EBP implementation projects are based on research studies that 
have been already completed and risks associated with the intervention already known. Because 
of this, patients are not exposed to new risks and informed consent is not usually required. This, 
however, does not mean that patients will not be exposed to any risks. Data collection from 
patients for evaluation of the intervention effectiveness can put patients at risk for privacy 
violation. (O’Mathunna, 2011). The practitioner must make sure that patient data that are 
collected are safeguarded to prevent violations of patient right to privacy. Some of the ways this 
can be accomplished is by putting the data in a password protected computer or also 
deidentifying patient names. All patient information that was collected was safeguarded and 
protected by deidentifying patient names and putting the data in a password protected computer. 
Patients were also protected from any harm that could be cause by the implementation. 
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Chapter 3 
Project Design and Methodology (EBP Process Steps 3-4) 
Project Design and Methodology Overview 
Staff education was completed on 1/19/18, this was followed by Institutional Review 
Board (IRB) review of the project to determine if it meets the requirement for IRB oversight. 
This process was initiated in January 2018 and was completed on March 8th, 2018 with 
exemption and approval of the project to move forward by IRB. SMA sessions started on 3/23/18 
and continued weekly four times, then two biweekly booster SMA sessions. Data analysis 
followed the booster SMA sessions, and this lasted through June 2018. Finally, dissemination of 
the project results began in January 2019 through July 2019, and sustainability plan will also 
continue through July 2019 (See Gantt chart in appendix L, table L) 
Resources Required for Project/Cost 
Resources are a critical part of the success of any project. The following resources were 
noted as critical to the SMA implementation: Office space, staff, computer with internet 
connection, furniture, device for indirect non-invasive mean arterial pressure (dinamap), 
electronic scale, educational materials such as flyers, booklets and posters, stethoscope, budget, 
HbA1c machine, monofilament, microalbumin machine, microalbumin strip, other medical 
equipment such as ophthalmoscope and otoscope office supplies such as printers, papers, stapler, 
and scanners. Staff payroll was also central to the success of the project. It was estimated that 22 
total SMA hours would be required to implement the project. Nurse practitioner, Registered 
Nurse and Certified Medical Assistant hourly pay was calculated and added to the total budget of 
the project. The total amount including staff pay roll and resources cost was $22,268.93 (See 
appendix K, table K). 
 14 
 
Fully Operationalized Project (Month by month-Week by week Project Plan) 
On November 2017, the University of Texas Southwestern medical center (UTSW) 
Advance Practice Department IRB application form was reviewed and completed.  
On December 2017, a conditional approval letter from Advance Practice Department at 
UTSW to move forward with the project pending IRB review for exemption was received. 
Project protocol was finalized during this month as well.  All the diabetic patients were notified 
regarding the upcoming SMA implementation in the clinic. All the stakeholders and industry 
mentor were notified about the date of the implementation.  
January 19th, 2018/Week 0 pre-implementation- On January 19th, the implementation 
team met to receive in-service training on the project protocol. We discussed the logistics of the 
project. All the resources were reviewed, including the room where the intervention took place. 
The clinic manager was not able to attend this meeting, but she was briefed on the project 
implementation on a different date. The process outcome of staff education on project protocol 
was completed on this day by the medical provider in the clinic. The entire project protocol was 
discussed using demonstration technique. We went through the project protocol week by week to 
rehearsed what is going to happen on each day of the implementation. We confirmed that 
patients have been informed about the upcoming SMA, and a choice was given to them to 
schedule appointments.   
March 23rd, 2018/Week 1 implementation- First week of implementation, baseline data 
was collected on this day. The following occurred during the first week of implementation:  
• Patient registration by the clinic medical assistant was carried out at the 
receptionist desk using EPIC EMR once patients walked into the clinic. Patients 
were escorted to the group room where vital signs, including weight were 
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collected by the clinic Registered Nurse (RN) and documented in the EPIC 
Electronic Medical Records (EMR) for each patient. Baseline data which 
included: HbA1c, BMI, blood pressure (BP), and lipid values, were queried from 
EPIC and values were transferred to Excel sheet by the nurse practitioner (NP). 
These values served as the baseline data. Diabetes knowledge test was also 
administered by the NP using University of Michigan Diabetes Research and 
Training Center Diabetes Knowledge Test in the group room. The scores of this 
initial test served as the baseline data.   
• NP reviewed patient charts in provider office by going through each participant’s 
chart while patients were being registered and vital signs taken. 
• Once all the patients were registered and seated in the group room, the 
appointment started with icebreaker session and introduction. The staff introduced 
themselves, and the NP asked each patient to introduce themselves to the group. 
Patients were also reminded of the Health Insurance Portability and 
Accountability Act (HIPPA) confidentiality rules by NP not to discuss any patient 
information outside of the meeting (See appendix E, table H). 
• NP sequentially attends to each patient in the group starting with brief medical 
history first, followed by brief physical examination and finally, discussion of the 
laboratory results including hemoglobin A1c and medication management with 
the participation of the group as peer support. Patients progress were discussed 
verbally in the group. Once every patient was seen, this marked the end of the 
appointment component of the visit. This segment lasted for about 5-10 minutes 
per patient 
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• After each patient’s open appointment in the group, the facilitators (RN and NP) 
conducted patient education with focus on diabetes self-management strategies, 
using various methods including, pictures, handouts, cards and blackboard. The 
curriculum included: diabetes overview (basics) including pathophysiology, 
acceptable laboratory values for A1c, hypoglycemia, glucose monitoring and 
complications; medication management, nutrition management, exercise, foot 
care and behavioral modification (See appendix C, Table E) Week 1 education 
was focused on diabetes overview: pathophysiology, and acceptable values for 
HbA1c. This education was conducted by NP in the group room using American 
Diabetes Association (ADA) professional resource handouts on HbA1c and 
diabetes pathophysiology. The mode of delivery was 
discussion/demonstration/handouts. Some of the following questions were 
addressed during educational sessions: What is diabetes? What causes it?  What is 
HbA1c? what are acceptable values? When is HbA1c measured? How is HbA1c 
different from serum blood glucose? And setting goals and making action plan. 
These are some of the questions and topics that was addressed in the educational 
session. This session lasted for 60 minutes (See appendix E, table H).  
• After the presentation, the floor was open for open discussion among patients 
with the provider as the facilitator. Patents asked questions, and they were also 
encouraged to share their success stories with their peers in the group. Patients 
who met their glycemic goals were praised and were encouraged to lead the 
discussion and educate those who were struggling with meeting their glycemic 
targets. This session lasted for 30 minutes.  
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• The session ended with each patient setting a clear achievable goal as to how they 
plan to improve their diabetes management before next meeting by writing the 
goal down on a paper. The session was adjourned until next week. 
March 29th, 2018/Week 2-  
• Patient registration by the clinic medical assistant was carried out at the 
receptionist desk using EPIC EMR once patients walked into the clinic. Once that 
was completed, patients were escorted to the group room where vital signs, 
including weight were collected by the clinic RN and documented in the EPIC 
EMR for each patient.  
• NP reviewed patient charts in the provider office by going through each 
participant’s chart while patients were being registered and their vital signs taken. 
• Once all the patients were registered and seated in the group room, the 
appointment started with introduction.  Staff introduced themselves, and the NP 
asked each patient to introduce themselves to the group. Patients were reminded 
of the HIPPA confidentiality rules by the NP (See appendix E, table H). 
• NP then sequentially attended to each patient in the group starting with brief 
medical history first, followed by brief physical examination and finally, 
discussion of the laboratory results including hemoglobin A1c and medication 
management with the participation of the group as peer support. While the NP 
was attending to each patient, the peers supported the patient by sharing similar 
stories. Patient’s progress was discussed verbally in the group. Once every patient 
was seen, this marked the end of the appointment component of the visit. This 
lasted for about 5-10 minutes per patient 
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• After each patient’s open appointment in the group, the facilitators (RN and NP) 
conducted patient education with focus on diabetes self-management strategies, 
using various methods including pictures, and handouts. Week 2 education was 
focused on diabetes overview. The discussion included hypoglycemia and glucose 
monitoring. The education was conducted by the NP in the group room using 
ADA professional resource handouts on hypoglycemia and glucose monitoring. 
Some of the following questions were addressed during educational sessions: 
defining what is hypoglycemia? What can you do to avoid it? What are the signs 
and symptoms of hypoglycemia? What are the complications of hypoglycemia? 
What types of food can you eat to avoid hypoglycemia?  The mode of delivery 
was discussion/demonstration/handout. Setting goals and making action plans was 
completed by each patient at the end of the SMA session. The session lasted for 
60 minutes.  
• After the presentation, the floor was opened for discussion among patients with 
NP as the facilitator. Patients asked questions, and they were also encouraged to 
share their success stories with their peers in the group. Patients who are doing 
well with meeting their glycemic goal were praised and were encouraged to lead 
the discussion and educate those who did not meet their glycemic targets. This 
session lasted for 30 minutes.  
• The session ended with each patient setting a clear achievable goal as to how they 
plan to improve their diabetes management before the next meeting by writing 
their goals down on a paper. The session was adjourned until the next meeting. 
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April 6th, 2018/Week 3 
• Patient registration by the clinic medical assistant was carried out at the 
receptionist desk using EPIC EMR once patients walked into the clinic. Once that 
was completed, patients were escorted to the group room where Vital signs, 
including weight was collected by the clinic RN and documented in the EPIC 
EMR for each patient.  
• NP reviewed patient charts in the provider office by going through each 
participant’s chart while patients were being registered and their vital signs taken. 
• Once all the patients were registered and seated in the group room, the 
appointment started with introduction. The staff introduced themselves, and the 
NP asked each patient to introduce themselves to the group. Patients were also 
reminded of the HIPPA confidentiality rules by the NP.  
• NP then sequentially attended to each patient in the group starting with brief 
medical history first, followed by brief physical examination and finally, 
discussion of the lab results including hemoglobin A1c, and medication 
management with the participation of the group as peer support. While the NP 
was attending to each patient, peers shared their experience with similar situation. 
Patient’s progress was discussed verbally in the group. Once every patient was 
seen, this marked the end of the appointment component of the visit. This lasted 
for about 5-10 minutes per patient 
• After each patient’s open appointment in the group, the facilitators (RN and NP) 
conducted patient education with focus on diabetes self-management strategies, 
using various methods including, pictures, and handouts. Week 3 education was 
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focused on diabetes complications and medication management. This education 
was conducted by the NP in the group room using ADA professional resource 
handouts on hypoglycemia and glucose monitoring. We discussed oral diabetes 
medications and the importance of adherence. We discussed which medications 
are insulin sensitizers, and those that can cause hypoglycemia. We also discussed 
insulin including self-titration using sliding scale, appropriate injection sites, and 
potential for hypoglycemia. We discussed diabetes complications which included 
macrovascular complications (coronary artery disease, stroke, and peripheral 
artery disease) and microvascular complications (retinopathy, nephropathy and 
neuropathy). The mode of delivery was discussion/demonstration/handout. 
Setting goals and making action plans was completed by each patient at the end of 
the SMA session. This session lasted for 60 minutes.  
• After the presentation, the floor was opened for discussion among patients with 
the NP as the facilitator. Patents asked questions, and they were also encouraged 
to share their success stories with their peers in the group. Patients who did well 
with meeting their glycemic goals were praised and were encouraged to lead the 
discussion and educate those who did not meet their glycemic targets. This 
session lasted for 30 minutes.  
• The session ended with each patient setting a clear achievable goal as to how they 
plan to improve their diabetes management before the next meeting by writing 
their goals down on a paper. The session was adjourned until the next meeting. 
April 13th, 2018/Week 4 
• Patient registration by the clinic medical assistant was carried out at the 
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receptionist desk using EPIC EMR once patients walk into the clinic.  Vital signs, 
including weight were collected by the clinic RN and documented in the EPIC 
EMR for each patient.  
• NP reviewed patient charts in the provider office by going through each 
participant’s chart while patients were being registered and their vital signs taken 
• Once all the patients were registered and seated in the group room, the 
appointment started with introduction. Patients were also reminded of the HIPPA 
confidentiality rules by the NP  
• The NP then sequentially attended to each patient in the group starting with brief 
medical history first, followed by brief physical examination and finally, 
discussion of the lab results including hemoglobin A1c and medication 
management with the participation of the group as peer support. While the NP 
was attending to each patient, peers shared their experience with similar situation. 
Patient’s progress was discussed verbally in the group. Once every patient was 
seen, this marked the end of the appointment component of the visit. This lasted 
for about 5-10 minutes per patient 
• After each patient’s open appointment in the group, the facilitators (RN and NP) 
conducted patient education with focus on diabetes self-management strategies, 
using various methods including pictures and handouts. Week 4 education was 
focused on nutrition management and exercise. (See appendix C, table E). This 
education was conducted by the NP in the group room using ADA professional 
resource handouts on nutrition management and exercise. We discussed about 
carbohydrate counting, nutrition labels, “my food plate”, eating out, meal 
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planning, heart healthy eating, food substitution, low fat diet, and DASH diet. We 
also talked about types of exercise, barriers to exercises, adopting an exercise 
regimen, and exercise and blood sugar. The mode of delivery was 
discussion/demonstration/handout. This session lasted for 60 minutes.  
• After the presentation, the floor was opened for discussion among patients with 
the NP as the facilitator. Patients who are doing well with meeting their glycemic 
goals were praised and were encouraged to lead the discussion and educate those 
who are struggling with meeting their glycemic targets. This session   lasted for 
30 minutes.  
• The session ended with each patient setting a clear achievable goal as to how they 
plan to improve their diabetes management before next meeting by writing the 
goals down on a paper. The session was adjourned until next 4 weeks 
April 20th/Week 5- 
• No SMA was conducted this week. Patients worked on their goals.  
• Individual medical appointments continued in the clinic this week.  
• NP reviewed process outcomes to make sure everything is on target.  
• NP prepared for the SMA booster session and reviewed the education materials 
for that session. 
April 27th, 2018/Week 6 SMA booster session 
• Project milestone was reviewed on 4/30/18 by the NP 
• Evaluation of number of patients still attending the SMA sessions was reviewed 
by NP.  
• Patient registration by the clinic medical assistant was carried out at the 
 23 
 
receptionist desk using EPIC EMR. Once was completed, patients were escorted 
to the group room where vital signs, including weight were collected by the clinic 
RN and documented in the EPIC EMR for each patient.  
• NP reviewed patient charts in the provider office by going through each 
participant chart, while patients were being registered and their vital signs taken 
• Once all the patients were registered and seated in the group room, the 
appointment started with introduction. Patients were reminded of the HIPPA 
confidentiality rules by the NP. 
• The NP then sequentially attended to each patient in the group starting with brief 
medical history first, followed by brief physical examination and finally, 
discussion of the lab results including hemoglobin A1c and medication 
management with the participation of the group as peer support. While the NP 
was attending to each patient, peers shared similar stories. Patients progress were 
discussed verbally in the group. Once every patient was seen, this marked the end 
of the appointment component of the visit. This lasted for about 5-10 minutes per 
patient 
• After each patient’s open appointment in the group, the facilitators (RN and NP) 
conducted patient education with focus on diabetes self-management strategies, 
using various methods including pictures and handouts.  Week 6 education was 
focused on foot care. (See appendix C, table E) This education was conducted by 
the clinic RN in the group room using ADA professional resource handouts on 
diabetic foot care. Proper foot care for diabetics, diabetes foot ulcers, and when to 
visit podiatrist was discussed. The mode of delivery was 
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discussion/demonstration/handout. Setting goals and making action plan was 
completed by each patient at the end of the SMA session. This session lasted for 
60 minutes.  
• After the presentation, the floor was opened for discussion among patients with 
the NP as the facilitator. Patents asked questions, and they were encouraged to 
share their success stories with their peers in the group. Patients who are doing 
well with meeting their glycemic goal were praised and were encouraged to lead 
the discussion and educate those who are struggling with meeting their glycemic 
targets. This session lasted for 30 minutes.  
• The session ended with each patient setting a clear achievable goal as to how they 
plan to improve their diabetes management before next meeting by writing their 
goals down on a paper. The session was adjourned until next 4 weeks 
May 4th/Week 7- 
• No SMA conducted in the clinic this week, patients worked on their individual 
goals.  
• NP was available to answer any patient questions in the clinic.  
• Individual medical appointments continued in the clinic. 
May 11th, 2018/ Week 8 
• Patient registration by the clinic medical assistant was carried out at the 
receptionist desk using EPIC EMR once patients walked into the clinic. Once that 
was completed, patients were escorted to the group room where vital signs were 
collected by the clinic RN and documented in the EPIC EMR for each patient. 
Weights were obtained, and BMI re-calculated again. Hemoglobin A1C was also 
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obtained on this day to compare the data to baseline information. Quarterly lipid 
values were ordered for patients who do not have a recent value in EPIC as 
completion outcome data. Blood pressure was obtained on this day to serve as 
completion outcome data. All these data were transferred to an Excel sheet for 
data analysis. 
• NP reviewed patient charts in the provider office by going through each 
participant’s chart, while patients were being registered and their vital signs taken 
• Once all the patients were registered and seated in the group room, the 
appointment started with introduction. Patients were also reminded of the HIPPA 
confidentiality rules by the NP 
• The NP then sequentially attended to each patient in the group starting with brief 
medical history first, followed by brief physical examination and finally, 
discussion of the lab results including hemoglobin A1c and medication 
management with the participation of the group as peer support. While the NP is 
attending to each patient, the peers shared similar experiences. Patients progress 
were discussed verbally in the group. Once every patient was seen, this marked 
the end of the appointment component of the visit. This lasted for about 5-10 
minutes per patient 
• After each patient’s open appointment in the group, the facilitators (RN and NP) 
conducted patient education with focus on diabetes self-management strategies, 
using various methods including pictures and handouts. Week 8 education 
focused on behavioral modification (See appendix C, table E) This education was 
conducted by the NP in the group room using motivational interviewing 
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techniques. Topics included readiness to change. The mode of delivery was 
discussion/demonstration/handout. This session lasted for 60 minutes.  
• After the presentation, the floor was opened for discussion among patients with 
the NP as the facilitator. Patients asked questions, and they were also encouraged 
to share their success stories with their peers in the group. Patients who were 
doing well with meeting their glycemic goal were praised and were encouraged to 
lead the discussion and educate those who were struggling with meeting their 
glycemic targets. This session will last for 30 minutes.  
• The SMA session ended on this day with re-administration of knowledge test that 
was administered on the first day of the implementation using University of 
Michigan Diabetes Research Training Center Diabetes Knowledge Test. The 
results were compiled and enter Excel sheet for analysis.  
• This session concluded the SMA sessions. All the patients were thanked for their 
attendance. 
Process Indicators with Lessons Learned, Barriers and Solutions  
There were several measures that were obtained during and after the intervention. The 
process outcome measures included: project protocol training, staff education, and data 
collection. These are processes that were required to achieve the project impact outcomes. Staff 
training, and education was measured by the rate of completion. The completion outcomes of 
SMA such as hemoglobin A1c, blood pressure, lipid values, knowledge, and BMI were 
measured at the end of the intervention (See Appendix I, table I) Other important outcomes such 
as financial impacts were measured as well as cost savings. The baseline HbA1c, blood pressure, 
lipid values, knowledge, and BMI were obtained from each participant before the intervention, 
 27 
 
and these values were obtained after the intervention again. The financial impacts were measured 
in terms of A1c reductions and prevention of potential complications. 
Model for Evidence-Based Practice Change/EBP Process  
Step 1 of The Model for Evidence-Based Practice Change (MEBPC) (See Appendix F, 
figure 1.1) was to assess the need for change in practice. In following the EBP process, the first 
step was to identify a clinical issue. Current national guidelines on diabetes recommend HbA1c 
goal of below 7% for adults in general and below 8% for the geriatric population. In my previous 
clinic, average hemoglobin A1c was 7.4%. National guidelines define normal BMI as less than 
25kg/m^2 and obese as BMI greater than 30kg/m^2; my previous clinic average BMI is 
36kg/m^2. In comparing the internal and external data, it is evident that improvement is needed 
to meet the national standards for hemoglobin A1c and BMI. The clinical issue in my former 
clinic was that some of the diabetic patients were not meeting the recommended hemoglobin A1c 
goal of less than 7%. A clinical question was then formulated to help locate the best evidence 
from the literature.   
Step 2 of the MEBPC model was to locate the best evidence with the clinical question as 
a guide. This is step 2 of the EBP process. Using systematic search strategy, a literature search 
was conducted. Using intervention, comparison, and outcome keywords from the PICOT 
question, CINAHL, PubMed, and Cochrane databases were systematically searched. The 
searches yielded articles with the following levels of evidence: two level I evidence, five level II 
evidence, six level III evidence, one level IV evidence, none level VI evidence, and one level VII 
evidence. 
Step 3 of the MEBPC model was to critically analyze the evidence. Step 3 of the EBP 
process is critical appraisal. Critical appraisal began with rapid critical appraisal of each 
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individual study, using GAO/RCA forms.  Relevant information was transferred from the 
GAO/RCA forms to an evaluation table, and then five synthesis tables were created on level of 
evidence, outcomes, SMA duration and frequency, SMA education curriculum, and SMA 
logistics. The outcome synthesis table verified that SMA has been shown to be effective in 
reducing hemoglobin A1c across 13 of 15 studies.  What stood out from the evidence synthesis 
was that SMA duration and frequency in the group sessions ranged from 1.5-4 hours, with most 
lasting 2 hours, how often SMA was conducted ranged from weekly to monthly, with most 
conducted weekly, and the total duration of SMA ranged three weeks to four years, with most 
lasted three months. For SMA education curriculum, DSME was common to all the studies. 
Most of the studies included: medication management, nutrition, exercise, behavior modification, 
diabetes overview and foot care. Most of the studies conducted SMA with small groups ranging 
between 4-20, with most using 4-6 patients per session. All the SMAs included medical 
management, DSME and peer support. The inter-professional team in the studies consisted of a 
medical provider, a nurse, a dietician, an exercise counselor, and a health psychologist. Most of 
the studies reviewed included just a medical provider and a nurse. The synthesis tables helped in 
the decision-making process of appraisal for practice change based on the evidence, and the 
recommendations. 
Step 4 of the MEBPC model was to design practice change.  This is step 4 of the EBP 
process. Once the body of the evidence is critically appraised, evaluated, and synthesized, it 
should be integrated with clinician expertise plus patient’s preferences and values to determine if 
it should warrant practice change. I have already had preliminary meetings with the clinic 
leadership including my industry mentor. During these meetings, we discussed what the evidence 
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revealed about SMA and what my vision moving forward for the clinic was going to be in terms 
of practice change 
Step 5 of the MEBPC model is to implement and evaluate change in practice. This is 
steps 5 & 6 of the EBP Process, in which application of the evidence to practice is evaluated. The 
protocol that was designed in step 4 guided all the implementation. Since the strategies and 
methods that were used in the studies was successful in reducing hemoglobin A1C, the same 
strategies were replicated in the project.  Based on the evidence, most of the studies used pre-and 
post -test to compare the effectiveness of the intervention. Pre-data were collected from all the 
patients at the beginning of the intervention, and post data collected after intervention. Baseline 
data included: A1c, BMI, blood pressure, lipid values, were queried from EPIC and values 
transferred to an Excel sheet by the NP. These values served as the baseline data. The project 
enrolled a small group of 4-6 patients per group session, meet weekly four times and two 
monthly sessions, and each session lasted for two hours per session as recommended from 
evidence synthesis. The total duration of the intervention lasted for three months.  
Step 6 of the MEBPC model is the integration and dissemination stage. The EBP process 
stage for this are steps 5 and 6, which are evaluation and dissemination of the outcomes. The pre-
intervention data was compared to the post intervention data to determine effectiveness. Based 
on the data, SMA was determined to be effective. Since SMA was effective, NP should make 
sure that the change is integrated and maintained into practice. NP should also promote 
evidence-based practice in organizations. SMA should be incorporated into the standard of care 
and clinical guidelines should reflect this change.  The results of the project will be disseminated 
through presentation and manuscript. 
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The DNP role in upholding ethical standards is important. Since EBP interventions are 
mostly conducted by the DNPs, they need to ensure that each step of the EBP process is 
observed and abides by the ethical standards. DNP needs to further ensure that the EBP 
implementation is in the best interest of the patient, and they also need to make sure that no harm 
is done to patients during the implementation. All patients need to be treated equally during the 
implementation as well. Lastly, DNP need to also make sure that patients’ autonomy and privacy 
are safeguarded.  
Theoretical Framework 
Self-efficacy is a concept which is derived from social cognitive theory and refers to an 
individual’s ability to perform his/her duties and responsibilities. This concept can be used to 
describe the interaction between personal and behavioral factors in chronic illnesses and predicts 
health behavior. Self-efficacy has been found to contribute to the self-management behaviors 
among patients with various chronic illnesses (Lalnuntluangi, Chelli, & Padhy, 2017). Several 
quantitative studies have explored the relationship between self-efficacy and self -management 
of diabetes. Among the studies that explored this relationship, Venkataraman et al. (2012) 
concluded that a strong positive association exists between self-efficacy and measured blood 
sugar status. The study also found that self-efficacy is the strongest determinant of current blood 
sugar status. Other studies including Lalnuntluangi et al. (2012), Greenberger et al. (2014), Gao 
et al. (2013), and Alipour et al. (2012) all had similar conclusions that higher self-efficacy 
translates into better self-management practices, better hemoglobin A1c, and better overall 
management of diabetes. Self-efficacy concept is, therefore, an important concept in diabetes 
management.  
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The health belief model (HBM) (See appendix G, figure 1.2) guided the SMA 
intervention. Perceived susceptibility/seriousness (severity) of disease is a patient’s 
understanding of the seriousness of the disease and susceptibility to the disease. Personal risk to 
the disease is a motivating factor to prompt people to adopt a healthier life style. The greater the 
risk is perceived, the higher the likelihood of behavior change to decrease the risk (Hayden, 
2009). This concept represents uncontrolled diabetes in this project.  Uncontrolled diabetes can 
lead to complications of diabetes, which represents a threat to the patient (perceived threat of the 
disease). Cues to action concept in the theory has a premise that people’s behavior can be 
influenced by cues to action. Cues to action are events, people, or things that lead people to 
change behavior. Examples are a family member having a heart attack, media reports, mass 
media campaigns, advice and education from a healthcare provider, and warning labels from 
products (Hayden, 2009). Through SMA, patients became aware of health threats from diabetes.  
During SMA sessions, patients collaborated with the provider and their peers by sharing valuable 
information regarding the management of diabetes. Peer support and disease knowledge 
represent modifying factors such as sociopsychology and structural variables. These individual 
characteristics such as peer support and knowledge of the disease can influence personal 
perception. They also help patients to be aware of the complications of the disease and the 
benefits of changing behavior (perceived - benefits of preventive action) (Hayden, 2009). 
Perceived benefits of the preventive action versus perceived barriers to the preventive action 
determines the likelihood of taking recommended preventive health action (Self -efficacy), 
which lead to the outcome of the intervention: reduced hemoglobin A1c, BMI, and blood 
pressure. 
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Logic Model 
The logic model guided the EPIP project in that it laid out the project assumptions, 
external influences, activities, inputs, outputs, and outcomes (See appendix H, figure1.3) The 
SMA assumptions were that diabetes patients will chose SMA over IMA. The external influence 
was that some patients might have difficulty with transportation, and they will not be able to 
attend SMA regularly. Another factor was the funding status of the primary care outreach 
program. Project input/resources were materials that were needed to conduct the project 
successfully. The following resources were needed for the project: Office space, staff, computer 
with internet connection, furniture, dinamap, electronic scale, educational materials such as 
flyers, posters, stethoscope, budget, HbA1c machine, other medical equipment such as 
ophthalmoscope and otoscope, office supplies such as printers, papers, and scanners. The 
activities were the process makers that determined the success of the project and how it was 
going. Meeting these processes makers timeline indicated that the project was going well. 
Outputs in the logic model are the number of SMAs conducted per week. Lastly, the outcome is 
divided into short, medium, and long term. The short-term goal is, patients recognize that 
uncontrol diabetes can lead to serious complications, the medium-term goal is, more patients will 
attend SMA visits, and the long-term goal is to achieve HbA1c < 7% each patient. 
The planning of the project involved designing of a logic model. This planning included 
outlining the activities of the project such as process makers.  All process makers were ethical 
and followed the decision triangle principles by making sure that the evidence and theory guides 
the logic model and ethical principles guides the decisions making. 
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Evaluation of EBP Model, Theoretical and Logic Model Function within EPIP 
The EBP model that guided the implementation of the project was the model for 
evidence-based practice change (See Appendix F, figure 1.1). Each of the steps of the model are 
like the EBP steps, which helped create a more coherent synergy between the model and EBP 
process. The health belief model (HBM) provided theoretical framework for the implementation 
of the EPIP. This model, in addition to the EBP and logic model, provided a philosophical 
guidance to the implementation. The logic model provided the inputs, output, and outcomes of 
the EPIP. The various concepts of the HBM, logic model, provided synergy with the steps of the 
EBP model, that helped provide motivation and self-efficacy, which helped some of the 
participants to change behavior.  
Quality Improvement Metrics for Sustainability  
The sustainability plan includes designing a new policy for a system wide 
implementation of SMA. The process of sustainability started on the day of implementation. This 
process is an important step in the implementation and will take several months (See Appendix 
L, table L). The new policy should be presented to the senior administrative officials for 
consideration. If the new policy is approved, system wide training should be conducted to 
prepare the staff for the system wide roll out of SMA. Once the SMA is implemented system 
wide, the sustainability plans should include clinic-based mentors who will be recruited to assist 
staff and answer any questions which they might have. These clinics-based mentors should be 
knowledgeable in the project protocol and SMA in general. A conceptual model such as 
advancing research and clinical practice through close collaboration (ARCC) should be used to 
strengthen EBP in organization as a system and to help sustain SMA in all the clinics. Another 
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strategy to sustain SMA is using the Plan-DO-Check-Act QI metric. This can help with ongoing 
quality improvement to further improve and sustain SMA in the organization  
Sustainability is a critical step in the EBP intervention process. The goal of EBP 
intervention is to provide the best practice to the patients and have plans in place to make sure 
that the best practice is sustained. It is unethical to embark on EBP intervention without any 
suitability plan. If an EBP intervention cannot be sustained, the valuable resources that have been 
invested in the intervention are wasted; this violates the ethical standard of justice.   
Project Approvals 
This project required three approval processes. One was required from the IRB office to 
make sure that all the regulatory policies are followed. This was in the form of a review, it 
required an initial two-page form consisting of yes or no questions to determine if the project 
will require a full IRB review application process. Based on the answers on the form, the 
reviewers determined that this project does not meet the requirement for IRB oversight. The 
department of Advance Practice at UTSW also approved the project. Lastly, the project also 
required the approval of University of Texas at Tyler.  
  
 35 
 
Chapter 4 
Project Outcomes, Impact, and Results (EBP Process Step 5) 
Completion Outcomes: Data collection, Data Analysis, Measurement, and Analysis of the 
Project Results and Impact  
Baseline data was collected from all patients on the first day of the intervention by the NP 
after completing the registration process. The information that was collected included:  
Hemoglobin A1c, blood pressure, lipid values, initial knowledge test, and weight to calculate 
initial BMI. Data on these outcomes were queried from EPIC EMR using the report tab, then 
selecting “my reports”, then choosing “my diabetes patient”, and then choosing “date range” and  
“run” to obtain results.  
The initial data was transferred to an Excel sheet. These values served as the baseline 
data. A diabetes knowledge test was administered by the NP using The University of Michigan 
Diabetes Research and Training Center Diabetes Knowledge Test in the group room. This was 
completed once the HbA1c, BP, and Lipid values baseline data collections were finished. The 
scores of this initial test served as the baseline data. Data was collected again post intervention as 
it was done in the studies. The HbA1c was measured using the usual Siemens DCA Vantage 
HbA1c Analyzer for those who did not have recent HbA1c in EPIC EMR.  Blood pressure was 
measured using Welch Allyn Dinamap; lipids were measured using the UTSW laboratory; an 
electronic scale was used to capture the weights of each patient to enable BMI calculation; and, 
knowledge was measured using University of Michigan Diabetes Research Training Center’s 
(UMDRTC) Diabetes Knowledge Test. The results of post-intervention data were compared to 
the baseline, and the aggregate mean reduction in the outcome values were noted and recorded. 
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The pilot intervention for SMA was implemented on March 23rd, 2018 through May 5th, 
2018. A follow up encounter to collect missing data was conducted on May 25th, 2018. Six 
patients participated in the intervention, but post-intervention data was collected on four patients. 
The two patients that participated were not available for post intervention data collection. Pre-
mean intervention data for hemoglobin A1c, systolic blood pressure, diastolic blood pressure, 
body mass index, lipid values, and knowledge was collected on the six participants and recorded. 
Post mean values were collected for HbA1c, blood pressure, BMI, and knowledge (See appendix 
M, figure 1.4) Lipid values were available for one of the four patients. Post-mean values were 
calculated on four patients who attended two or more SMA sessions. Pre- and post-mean values 
were calculated for participants who attended three or more SMAs (See appendix M, figure 1.5). 
In July of 2018, a retrospective chart review of SMA was conducted at North Dallas 
Shared Ministry (NDSM). Data was collected on 17 patients who participated in SMA from 
January 2017 to June 2018. Out of the 17 patients, 13 were females and four were males.  The 
age range was from 32-66 years. Data was collected on outcome values of hemoglobin A1c, 
blood pressure, lipid values and body mass index. Data analysis revealed that outcome values 
improved, but were not statistically significant (See appendix M, table M). HbA1c improved 
from a pre-mean of 8.0% to a post mean of 7.5% (p=0.139); systolic blood pressure decreased 
from a pre-mean of 133 mmHg to a post=mean of 126 mmHg (p=0.145); diastolic blood 
pressure decreased from 81 mmHg to 75 mmHg (p=0.043); total cholesterol improved from a 
pre-mean of 190 mg/dl to a post-mean of 183 mg/dl (p=0.337); LDL improved from a pre-mean 
of 99 mg/dl to a post-mean of 95 mg/dl (p=0.433); and, HDL improved from a pre-mean of 47 
mg/dl to a post-mean of 48 mg/dl (p=0.470).  Triglycerides, however, increased from a pre-mean 
of 221mg/dl to a post-mean of 222 mg/dl (p=0.985);  and, body max index improved from a pre-
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mean of 35 kg/m2 to a post-mean of 34 kg/m2 (p=0.139) ( See appendix M, figure 1.7).  Another 
key finding includes the percentage of patients reaching their HbA1c goals which increased from 
25% to 38% post-intervention (See appendix M, figure 1.9). The number of patients at goal for 
hypertension increased from 65% to 88% (See appendix M, figure 2.0).  
Evidence from the literature was synthesized and presented in synthesis tables to better 
visualized the effects of SMA on outcomes. Each of the studies in the synthesis tables in body of 
evidence indicated that SMA was effective in reducing HbA1c, BP, BMI and lipid values levels. 
SMA was also found to increase patient knowledge. Findings in the pilot SMA and the 
retrospective chart review are consistent and comparable with the evidence. In the pilot SMA 
implementation, the average values for HbA1c, BP, and BMI all decreased post-intervention 
evaluation as suggested in the body of the evidence. The reductions in these values are more 
pronounced for patients who attended greater than three or more SMA sessions. Knowledge 
increased from 52% to 92% post intervention (See appendix M, figure 1.4). Lipid values were 
not evaluated due to very limited data. For the retrospective chart review, findings suggest 
reductions in the HbA1c, BP, BMI, and lipid values (See appendix M, figure 1.7). 
Projected Project Costs/Savings 
Based on the evidence, the implementation of SMA is effective in helping patients to 
meet their hemoglobin A1C goals and effectively achieve disease management outcomes. 
However, the budget is an important element of any project planning endeavor, as well. Without 
financial resources the project cannot be brought to actualization. The cost of diabetes care in the 
US is rising, and patients with diabetes complications incur more costs, placing severe burdens 
on the entire healthcare system. Implementation of SMA, helping patients meet their glycemic 
targets and avoiding complications that make diabetes care cost-prohibitive, result in substantial 
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cost savings. Resources that will otherwise be used for diabetes complication care, can be 
diverted to combat other chronic conditions. SMA has also demonstrated to improve the 
productivity of medical providers and, thereby, increase revenue for the organization (Caballero, 
2015).  Considering the evidence gathered regarding SMA, an organization can design and 
incorporate policies that will integrate SMA as the standard of the care, achieving optimal 
outcomes and maximize use of resources. 
The cost of diabetes care varies depending on the type of care and where the care is being 
rendered. It is a well-established fact that when a diabetic patient seeks care in the Emergency 
Department (ED), the cost of care is usually higher than that of a diabetic who seeks care in 
his/her primary care provider’s office. The cost of care goes even higher if the person is admitted 
to the hospital for a diabetes complication. For example, data from my former organization 
revealed an average of $298 per visit if a diabetic seeks care in a primary care provider’s office. 
The amount increased to an average of $2682 if the same care is rendered at the ED. The cost of 
care further increased to $27,992 if the patient is admitted to the inpatient (hospital) setting with 
diabetes complications (See appendix J, table J). 
 Considering the costs noted above, in addition to various diabetic care costs, a significant 
amount of money can be saved if we can keep patients in the primary care arena. For example, 
we can save up $2384 if the patient can avoid using the ER for diabetes care. We can also save 
up to $27,693 per visit if we can prevent diabetes complications and prevent inpatient 
hospitalizations. Based on five-day hospitalization care cost, we can expect a return in 
investment savings of $1.993,968 per year if we can keep patients out of the hospital.  
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Chapter 5 
Project Sustainability Discussion, Conclusions, and Dissemination Recommendations 
(Step 6) 
Discussion of Project Results and Impact  
The results of the pilot SMA were mixed. In comparing the pre-mean of the participants 
to the post mean of the outcome values, HbA1c, blood pressure, and BMI dropped slightly, but 
the post mean knowledge increased significantly (See appendix M, figure 1.4). In comparing the 
pre and post mean of the HbA1c, the results indicate that those patients who consistently 
attended SMA sessions and attended greater than three sessions have seen a significant drop in 
their HbA1c values. For example, the patient with the project identification number 1003, had 
consecutively attended all the first three SMAs plus an additional day, and his HbA1c dropped 
from 10.2% to 6.9% (See appendix M, figure 1.6). This patient attended a total of four SMAs. 
This indicates that the dose of SMA had an impact on this patient’s HbA1c level. In comparing 
to the patients who attended at least two SMAs, but were not consistent with attendance, have 
seen a slight increase in HbA1c level. Two out of three patients who also attended three or more 
SMAs have seen a drop in their body mass index compared to pre-intervention values (See 
appendix M, figure 1.6). 
Although the results of the retrospective chart review outcome measures improved from 
baseline, but the improvements were not statistically significant. This might be due to the small 
sample size of the participants. Only the diastolic BP outcome was statistically significant 
(P=0.043) (See appendix M, table M). The results of both the pilot SMA intervention and 
retrospective chart review revealed that SMA outcomes improved including hemoglobin A1c 
(See appendix M, figure 1.8). The reduction that was achieved in the interventions was predicted 
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in the body of the evidence. Despite the interruption that occurred during the pilot SMA 
intervention and the impact it had on the attendance of the SMA sessions, the mean HbA1c still 
improved. Some of the patients’ HbA1c did not improve or slightly improve; this can be 
attributed to the clinic closure announcement that lead to some of the patients to seized attending 
the SMA sessions. The results of this intervention should, therefore, pave the way for adoption of 
SMA as the standard of care for management of patients with diabetes.  
Role Impact Plan 
The role of Doctor of Nursing Practice (DNP) is important in every aspect of 
contemporary healthcare delivery. Collaboration is an important concept in healthcare. To 
achieve the desired system and patient outcomes, DNP must form strategic partnerships with 
other members of the healthcare team to manage interdependent and interdisciplinary 
relationships.  DNP role requires the socialization and interpersonal skills to establish strong 
foundations for collaboration, negotiation, consultation, and clinical leadership.  (Smith, Vezina, 
& Samost, 2013).  For the DNP role to have a meaningful impact that improves outcomes, 
collaboration must be one of the key pillars of the practice. Collaboration means to work together 
in a joint intellectual and the qualities includes: common focus, recognition of one another’s 
expertise, and collegial exchange of ideas and knowledge (Smith, Vezina, & Samost, 2013). The 
qualities of collaboration and negotiation are therefore necessary for the DNP role to have impact 
in healthcare.   
My current organization has strong structures in place that are favorable and will enable 
the DNP to disseminate EBP within the organization. It has an office that deals with emerging 
EBP and research studies and incorporates these findings into standard of practice. Presenting the 
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EBP findings to this department will increase the chance of adoption of SMA as the standard of 
care for diabetes management across all the clinics within the system. 
The DNP growth in my current organization in recent years is notable. This organization 
went through a recent restructuring regarding Advance Practice Providers (APP) practice. New 
roles where created for leadership in the community outpatient primary care (COPC) for APP 
practice. Now most of the COPC clinics are led by APPs. Initially, this organization did not have 
such structures in place. Advance Practice Registered Nurse (APRN) counsel and the office of 
evidence-based practice are also led by DNP and PhD prepared nurses. DNP foundation in this 
organization is, therefore, on a strong footing and expected to grow significantly in the coming 
years. The weakness of the role of the DNP in this organization is that there is no specified role 
other than leadership for the DNP prepared APP who is on the floor seeing patients. There is an 
opportunity that can be seized to create a specified role for the DNP prepared APP such as the 
leader who directs all the care and promote evidence-based practice. There are also no monetary 
incentives for obtaining a DNP as an APP on the floor.  If organizations do not have incentives 
to encourage APPs to go back to school to get DNP, the number of APPs who will go back to 
school to get a DNP degree will drop significantly. This threat needs to be considered with 
seriousness. Achieving a DNP degree requires significant financial and other resources. If 
APRNs sense that there is no incentive, then they will not be compelled to get the degree.  
Discussion of Project Sustainability Plan and Healthcare Policy  
Sustainability is a key part of the EBP process. If the gains that have been achieved 
during the implementation cannot be sustained, the whole exercise becomes futile. Using 
evidence-based models can help achieve sustainability in EBP.  One such model is the ARCC 
model. The basic premise of this model for sustainability is: Barriers to EBP must be removed 
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and replaced with facilitators, for clinicians to adopt evidence-based practice, their beliefs about 
value of EBP and confidence must be strengthened, and EBP culture that includes mentors is 
necessary to sustained EBP in healthcare systems (Melnyk, Fineout-Overholt, Gallagher-Ford, & 
Stillwell, 2011). 
Sustainability of an intervention that has shown to improve health outcomes is important 
to the overall health care delivery. SMA has shown to save cost and improve outcomes for 
diabetes patients. Therefore, sustainability of this evidence-based practice intervention is 
paramount. SMA does not only increased revenue for a healthcare organization, but it can also 
reduce the cost of healthcare spending. A provider can see up 10- 15 patients in a 90-minute 
visit, versus seeing four patients in traditional clinic visit. Seeing more patients in clinic 
translates to more revenue. SMA can also help improve outcomes for diabetes patient, reducing 
the number of times they seek care to the emergency room which is expensive. If seeking care to 
the ER can be avoided, healthcare cost can be reduced. Moreover, keeping diabetes patient 
healthy and avoiding complications also means no missed work days due to diabetes, and 
therefore no lost income.  
Healthcare access is an important first step in improving outcomes. Access is the ability 
to obtain needed, affordable, convenient, acceptable, and effective healthcare in a reasonable 
time frame (Damron, Chapman, & Outlaw, 2016). Despite the passage of the Affordable Care 
Act (ACA), access remains a challenging problem for some patients, especially the underserved 
community. Under the ACA, states are supposed to expand Medicaid to improve access to more 
people. However, some states refused to expand Medicaid leaving some of the patients who need 
access to health care without any health coverage. Expanding care to more patients through 
health care policy changes which can be achieve through legislation, will ensure that EBP 
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interventions such as SMA are sustained and continue to improve outcomes. It is morally and 
ethically wrong to not extend an effective intervention to all patients that can benefit from it. 
Improving access to healthcare will ensure that delivery of healthcare is improve as well.  
Health policy is an important process which nurses need to get involved in every step of 
the way. It includes all the activities that are involved in policy design, including those activities 
that design to lobby legislators or policy makers (O’Grady, 2015).  The first step in in 
development of a policy that will impact sustainability of my project is to present the evidence to 
the policy makers. Policies that will help the sustainability of SMA at local level, can be in the 
form of expanding care in local, national and global levels. For example, since Texas did not 
expand Medicaid, one can argue and present the evidence that expanding care will help improve 
care and save cost. At a national level, congress can strengthen the ACA which already has 
structures in place to increase access to care. At global level, organizations such as WHO can 
design policies such as programs that will help extend access to care for people who lack access. 
Once care access is increased at all levels, then more diabetic patients will have care through 
different innovative ways such as the SMA. This will help sustain the SMA and continue to 
improve outcomes. 
Implications for EPIP Results 
The findings from the implementation of SMA suggest that the concept of diabetes 
management in a group setting has had a positive effect on the health outcomes of diabetes 
patients.  As suggested in the body of the evidence and seen during the implementation, SMA 
has the potential to improve the efficiency of healthcare providers. This also helps practices 
generating more revenue, which in turn help organizations to meet their budget objectives. 
Patients also have the additional benefit of longer visits with primary care provider and learning 
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and receiving support from peers with the same diagnosis. The results are also a testament that 
Advance Practice Nurses can independently design and implement evidence based innovative 
projects that can improve the health of our patients and the community as whole.  
Key Lessons learned from EPIP Implementation 
The three key takeaways from this project implementation are: 1) The project manager 
must be ready to respond to unanticipated problems and a plan put in place to mitigate those 
unforeseen issues 2) if one follows the interventions as stipulated in the body of the evidence, 
one may also expected to get results similar to those represented in the body of the evidence 3) 
EBP interventions can improve patient outcomes.  
Many aspects of SMA implementation went well; and some did not. This is to be 
expected with any EBP implementation. The clinic closure in the organization where I 
implemented the SMA affected my project immensely. Therefore, this aspect of the 
implementation did not go well. If I can repeat the implementation at another site, I will be more 
selective of the location to be assured that the project will not be interrupted in the middle of 
implementation. In terms of what went well, I followed the interventions from the body of the 
evidence, and I achieved the results represented in the body of the evidence. I also followed the 
project implementation plan, even though I had to make some adjustments due to the clinic 
closure. 
The intervention of the SMA pilot revealed some findings that raised questions that need 
to be further pursued for answers. For example, one participant consistently attended the sessions 
and has seen a significant drop in his HbA1c. However, some of the other patients who attended 
fewer sessions also seen an improvement in outcomes. A question that arises from this is that 
how much dose of SMA is needed to achieve improved outcomes? A well design quantitative 
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study might be needed to answer this question. This will be important for practice because if for 
example four weeks of SMA is as effective as three months of SMA, then utilizing four weeks of 
SMA will help save time and resources. 
Conclusions 
Based on the results of both the pilot and retrospective chart review, SMA is an effective 
and innovative intervention that has demonstrated improvement in hemoglobin A1c, blood 
pressure, lipid values body mass index and knowledge, compared to individual visits 
Dissemination Plan  
Dissemination of evidence is an important part of the EBP process. Sharing information 
that can improve patient outcomes is not only a responsibility of the scholar, but also moral and 
ethical responsibility. Newly discovered evidence will not achieve its maximum value and 
improve outcomes unless it is disseminated through a medium that can reach wider target 
audience (Betz, Smith, Melnyk, & Olbrysh, 2015). Dissemination of the evidence findings will 
be in form of power point presentations, poster, and manuscript. Another plan that is 
consideration is poster or PowerPoint presentation that is delivered via podcast or posted in 
Google Scholar. This will reach a wider national audience of clinicians. Another advantage of 
this is also once the content is archived, it can be used by clinicians any time at their convenience 
(Betz, Smith, Melnyk, & Olbrysh, 2015). 
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Appendix A: Systematic Search Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                    Figure 1.0. Systematic Search results showing final yield of research studies   
CINAHL= 19 
PubMed= 11 
Cochrane = 12 
Total=    42 
Final studies included in the 
review was 15 
2 level 1 
5 level II 
6 level III 
1 level IV 
1 level VII 
 
27 total articles excluded 
due to: 
Duplicates 
Study protocol  
Not relevant to the topic 
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
 
 
Appendix B: Evaluation Table 
 
Table A  
  Evaluation Table Showing Research Studies  
 
Citation: 
author(s), date 
of publication& 
title 
Purpose of 
Study 
Concept
ual 
Framew
ork 
Design/ 
Method 
 
Sample/ 
Setting 
Major 
Variables 
Studied and 
Their 
Definitions 
 
Measurement 
of Major 
Variables 
Data 
Analysis 
 
Study Findings 
Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 
evidence + quality [study strengths and 
weaknesses]) 
RECOMMENDATIONS 
Riley, B.,S. 
(2012). Imp. 
diabetes 
outcomes by an 
innova. group 
visit model: a 
pilot study. 
JAANP, 25 (9).  
 
 
USA 
 
 
 
 
 
 
 
 
 
 
To develop 
SMA model 
that improves 
Hgb A1C 
results, BP, 
lipids, 
depression, 
and 
satisfaction 
among PT. 
with DM that 
can be used in 
PC. 
TTM 
(Stages 
of 
change 
theory) 
 Pilot study 
pre/post test  
 
Intervention: 
Method: 
Interactive 
SMA SMART 
board. and 
hands on 
activity. 
 
Duration: 2 hrs  
1st hour for 
group activities  
 2nd hour for 1on 
1 visit with NP. 
 
Program:  
monthly X 3 
 
# of PT per 
session: 4-20  
 
Staff: NP, MA 
 
N= 22 adult  
 
PT who all 
had DX of 
DM with 
A1C 7.5 or 
>, with 80% 
of them 
females and 
32% were 
black.  
 
 
 
Setting: 
Private 4 
provider FP 
in rural area 
IV: SMA 
(SMART 
board , an 
interactive 
electronic 
white board 
was utilized 
for teaching) 
 
DV:  
DV1:HgbA1c 
DV2: Wt. 
DV3:,BP 
DV4: Lipids 
DV5: 
Depression 
DV6: Patient 
Satisfaction 
 
 
DV1- % 
reduction 
DV2- Scale 
DV3- BP 
machine  
DV4-lab 
DV5: BDI 
DV6: SOSQ 
 
 
 
 
P value  
 
DV1= ↓ A1c 
MR= 1.1 points 
(p=0.009) 
 
DV2= 3.01lb MR 
(p=0.001) 
 
DV3= DBP ↓ by 
a mean of 
5.76mmhg (p= 
0.002) 
 
DV4= LDL 
(p=0.747) not 
statically 
significance 
 
DV5: Depression 
(P=0.045) 
 
DV6: PT 
satisfaction 
(P=0.028) 
Weakness: 
• Small sample size 
• Non RCT 
• Lack of uniform representation 
on race 
• Short duration(Pilot) 
• Names of instrument used for 
measurement not provided 
Strengths 
• Level III evidence 
• Significant improvement in 
DVs 
Conclusion: 
SMA reduces A1c, BP Wt.; Lipids ↔; 
depression improved and PT satisfaction 
↑ 
 
Risk/Benefit: Benefits of the study 
outweigh risks 
 
Recommendations: 
• Level III study, and the findings 
agree with higher level studies.  
• But it was a pilot study. 
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
 
 
Citation: 
author(s), date 
of publication& 
title 
Purpose of 
Study 
Concept
ual 
Framew
ork 
Design/ 
Method 
 
Sample/ 
Setting 
Major 
Variables 
Studied and 
Their 
Definitions 
 
Measurement 
of Major 
Variables 
Data 
Analysis 
 
Study Findings 
Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 
evidence + quality [study strengths and 
weaknesses]) 
RECOMMENDATIONS 
SMA technique: 
(MM, DSME, 
PS) 
 
DSME 
curriculum: diet, 
exercise, 
medication, 
complications, 
health coping 
Recommend cation and gather 
more information before using 
as the standard of care  
Watts et al, 
(2015). SMA for 
PT with DM: 
Glycemic 
reduction in 
high-risk 
patients. 
JAANP, 27 (8). 
450-456.  
 
 
 
 
 
USA 
 
 
 
 
 
 
 
To assess the 
impact of GC 
by measuring 
A1C in a PC 
urban VA 
SMA 
None Retrospective 
pretest/posttest 
study. 
 
Method: 
Data was 
extracted from 
hosp. EMR and 
registry. 
Patients served 
as their own 
control, A1c 
levels were 
averaged for 
PTs who 
attended SMA 
from 4/06 to 
12/10.  
N=1290 PT  
 
 
96% of them  
males.  
 
All the PT 
were 
recruited at 
the VA and 
had DX 
T2DM and 
at high risk 
for CM 
(A1C >9 and 
SBP>160m
mhg) 
 
Setting: 
Clinic 
(Lours 
Stokes 
IV: SMA 
 
DV: Hgb A1c 
DV- HgbA1C= 
% reduction,  
 
DS-DSI 
 
 
 
 
Paired t 
test was 
conducte
d for PT 
who had 
at least 
one A1c 
measure
ment in 
the 180 
period . 
DV; Hgb A1c 
↓(1%)  overall 
(n=1170)  
 
  
Linear regression 
analysis showed a 
significant (p 
=0.001) pre-SMA 
positive trend 
(r2=0.90) 
 
DSI ± 3.01 
Weakness: 
• Single site study   
• Pretest/post-test design and 
lacked control group 
• The number and timing of A1c 
measurement varied widely  
Strengths: 
• Longitudinal study 
• Large sample size of 
1290patients  
• Positive sustainability > 4years  
• Intervention reduce over 9% of 
A1c 
• Level III evidence 
 
Conclusion: 
A1C ↓ in high risk diabetic PT 
 
Risk/benefits: Benefits outweigh risks  
 
 
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
 
 
Citation: 
author(s), date 
of publication& 
title 
Purpose of 
Study 
Concept
ual 
Framew
ork 
Design/ 
Method 
 
Sample/ 
Setting 
Major 
Variables 
Studied and 
Their 
Definitions 
 
Measurement 
of Major 
Variables 
Data 
Analysis 
 
Study Findings 
Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 
evidence + quality [study strengths and 
weaknesses]) 
RECOMMENDATIONS 
 
 
 
 
Cleveland 
VA MC) 
 
Attrition=N
R 
 
Recommendation:  
• Level III evidence and 
longitudinal study. 
• Findings agrees with higher 
level studies  
•  Will recommend as the 
standard of care  
Jessee et al, 
(2012) 
Effectiveness of 
NP coordinated 
team GV for 
T2DM in MU 
Appalachia. 
JAANP, 24, 735-
743.  
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 Effectiveness 
of 
multidisciplina
ry NP 
coordinated 
team SMA in 
MU area on 
health, SE, and 
knowledge of 
PT. with 
T2DM. 
Bandura
’s (1977) 
model of 
self-
efficacy 
Quasi 
experimental 
study  
 
Convenience 
sample. 
 
Subjects were 
assigned to 
comparison or 
study group 
 
Intervention: 
SMA method: 
  
Duration: 4 
hours  
 
# of PT per 
session: 11 
 
Curriculum: 
Visit#1: 
Inclusion 
criteria:   
 
subjects age 
21 and older 
with 
diagnosis of 
T2DM and 
A1C of >7.  
 
N=11(NPCT
)   
 
N= 15 
(IMA)  
 
 
 
Exclusion: 
Being <21, 
no T2DM, 
or A1c <7  
 
IV1:  was 
called “type 
of care”.  
 
Intervention 
group 
participated in 
NPCT group 
visits 
integrating 
DSME and 
MM with 
team 
approach. 
 
IV2: IMA 
 
DV: 
DV1: BS 
DV2: A1c 
DV3: 
knowledge, 
DV4: SE 
 
DV1-mean 
reduction 
 
DV2-% 
reduction 
 
DV3-mean ↑ 
(UMDRTC) 
 
DV4-mean SE 
(DESSF) 
 
 
Mean 
comparis
ons of 
the 
groups 
pre/post 
blood 
sugars, 
A1c , 
knowled
ge and 
self-
efficacy  
DV1= Study 
group’s averaged 
post BS ↓ 
27.24mg/dl more 
 
 DV2= Average 
post A1c ↓ 0.8% 
> the comparison 
group. 
  
DV3= Mean post 
knowledge ↑  
 
DV4= SE scores 
↑ 1.26 points  
 
 
 A1c improved 
2.0% in the study 
group, but only 
0.9% post 
intervention in 
the comparison 
Weakness: 
• Non-randomization of the 
subjects 
• Small sample size  
Strengths: 
• Level III evidence  
• Noted improvement in all the 4 
variables measured  
• Experimental study with 
intervention and comparison 
groups  
 
Conclusion: 
SMA ↓ A1C and BS, knowledge, and SE 
↑ 
 
 Risk/Benefit: Benefits outweigh risk  
 
 
Recommendations: 
• Level III evidence that agrees 
with level I and Level II 
studies. 
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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evidence + quality [study strengths and 
weaknesses]) 
RECOMMENDATIONS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DM Overview 
Nutrition 
BM, stress, 
coping, SE, 
goals, planning, 
medications (1 
hr) 
 
Visit#2 
Visit to grocery 
store, food 
labels, food 
purchases, food 
alternatives  
 
Visit#3 
Foot care, 
nutrition, 
progress and 
goal review, 
medications  
 
Program: 
Weekly X 3 
 
Staff:  
Faculty Advisor 
Dietician  
Pharmacist  
Counselors  
Nurse 
MD 
Attrition=N
R 
group, with 1.1% 
difference. SE 
scores improved 
0.49 points more 
than CG  
• Recommend as the standard 
of care  
 
 
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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SMA technique 
(MM, DSME, 
PS) 
Reitz et al, 
(2012). The 
effects of SMA 
program on 
outcomes of DM 
care in an urban 
family practice. 
Journal of 
Urban Health, 
89 (4). 709-716.  
 
 
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 To evaluate 
the effect of 
DM support 
and education 
SMA program 
on the 
achievement 
of Hgb A1c , 
LDL, and BP, 
and on Wt. 
changes 
several months 
after the 
program 
began. 
None None RCT 
matched 
controlled pre 
and post- test 
study. 
 
Method: 
Baseline 
variables 
collected for 
both groups, 
and compared to 
7 months F/U 
data 
 
Intervention: 
SMA method:  
 
Duration: 3 
hours  
 
# of PT per 
session: Not 
stated  
 
DSME 
Curriculum: 
Diabetes  
PT at least 
18 years of 
age,  
 
 DX of 
T2DM,  
 
 At least one 
visit to the 
practice 
between 
2008-2009. 
 
N=52(SMA) 
 
N=236(IMA
)  
 
Setting: 
Clinic 
(Jefferson 
Family 
Medicine) 
IV1: SMA  
 
IV2: IMA 
 
DV:  
 
DV1: Hbg 
A1C 
DV2: LDL 
DV3: BP 
DV4: Weight  
DV1-CMH  
DV2-propotion 
DV3- CMH 
DV4-Propotion   
Cochran 
Mantel 
Haenszel 
(CMH), 
 
P value  
 
DV1 =↑ 
proportion of pts 
who met target 
A1C 
<7(CMH=4.6613, 
p=0.0309), Hgb 
A1c ↓ 76.9% of 
the participants in 
the SMA 
compared to 
54.3% in the 
comparison group 
(CMH=8.9911, 
p=0.0027) 
 
DV2= No 
statistical 
significance 
achieved 
 
DV3= ↓BP 
<140/90(CMH=5.
61, p=0.018) 
compared to the 
comparison 
group.  
 
Weakness: 
• Lack of randomization  
Strengths: 
• Level III evidence  
• Multiple ethic representation  
• Positive improvement in DV 
• Control group 
 
Conclusion: 
• SMA improved patient 
management of diabetes 
 
 
 
Risk/benefits: Benefits outweigh risks  
 
Recommendation:  
• Level III evidence that agrees 
with level I studies    
• Recommend as the standard of 
care   
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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Nutrition 
BGM 
Complications  
 
Program: 
4 weeks  
 
Staff:  
DE 
Nurse 
Pharmacist 
Provider  
 
 
SMA technique: 
 (MM, DSME, 
PS) 
 
 
DV4= wt. loss 
was similar 
across the groups 
Caballero et al, 
(2015). Effect of 
group medical 
appointments on 
GC of PTs with 
T2DM. SD, 28, 
(4).245-250 
 
 
 
 
 
 
 Evaluate 
effect of SMA 
on A1c  
None Cohort Study 
Design 
 
Method: 
Retrospective 
electronic chart 
review  
 
Sample: N=104 
male PTs with 
T2DM. 
 
Intervention:  
Total sample 
N=104 
SMA: 
52/1245 
randomly 
selected .  
Control: 
52/352 
randomly 
selected . 
 
Inclusion for 
intervention: 
IV1:  SMA: 
IPP team 
evaluation + 
Education 
 
IV2: 
Individual 
visits by PCP 
 
DV: Hgb A1c  
DV- Hgb- % 
proportion 
target A1C 
goal 
Pearson’
s X2, 
 
P value 
IMA cohort rate 
of ↓ in A1c (-
0.001% per week 
P=0.912), 
X2=0.012   
 
SMA cohort rate 
of ↓ in A1c over 
time (-0.031% 
per week, 
p<0.001), 
X2=45.679. 
 
Weakness: 
• Retrospective design without 
randomization   
• All male subjects in single 
clinical site  
  
Strengths:  
• Intervention and control group 
compared. 
• Level IV evidence 
• Records were randomly 
assigned  
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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SMA method: 
 
Duration: 1.5 
hours  
 
# of PT per 
session: 8-15 
 
 
Program: 12 
months 
 
DSME 
curriculum: 
Diabetes  
Nutrition 
Exercise  
Medications  
Psychosocial 
LSM 
 
Staff:  
NP 
Pharmacist 
Nurse  
Health -
Psychologist  
 
SMA technique:  
(MM, DSME, 
PS) 
 
T2DM A1c 
>8.0, took 
part in SMA 
within last 
12 months. 
 
Inclusion for 
control: 
T2DM, seen 
by PCP 
within last 
12 months  
 
Setting: 
OPC (VA 
Loma Linda 
Healthcare 
system and 
its CBOCs) 
 
Attrition: 
NR 
 The difference in 
the rates of ↓ 
between the SMA 
and IMA cohorts 
was significant 
(p=0.003). 
 
 
• Positive findings from the 
intervention  
Conclusion: 
• 50% of SMA versus 19.2% IMA 
PT reached target A1C goals.  
• SMA PT had faster rate of A1C 
↓ than IMA.   
 
 
Risk/benefits: Benefits outweigh risk 
 
Recommendation:  
• Level IV evidence that agrees 
with high level studies. 
• Recommend as the standard 
of care  
 
 
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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Edelman et 
al,.(2014) SMA 
for PTs with 
DM: A systemic 
review. Jour. of 
Gen. Inter. 
Med.,30 (1) 99-
106. 
 
 
 
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SR of the 
existing 
literature on 
SMA 
interventions 
for PTs with 
DM in order to 
understand 
their impact on 
outcomes 
None SR of existing 
literature on 
SMA 
 
Searched 5 
database: 
MEDINE, 
EMBASE, 
CINAHL, 
PsycINFO and 
web of science.  
 
Publications 
from January 
1996 through 
April 2012, to 
compare SMA 
with IMA. 
 
Inclusion: Of 17 
total studies, 13  
RCTs,  4 
observational 
studies  
 
SMA 
techniques 
across studies: 
 
N=1172 
citations  
 
MEDLINE 
(n=397),  
 
CINAHL 
(n=290),  
 
Embase 
(n=145), 
 
PsychINFO 
(n=157)  
 
Web of 
science 
(n=186)  
 
Manual 
search (n=2) 
a total of 
1174 
citations.  
 
Inclusion 
and 
exclusion 
IV: SMA 
 
DV:  
DV1:HgbA1c 
DV2: BP 
DV3: 
Cholesterol 
DV1: % 
reduction 
DV2: mean 
reduction 
DV3: Mean 
reduction 
Forrest 
plot, 
Mean, 
 
 
DV1=SMA ↓ 
A1C (∆ =-0.55 % 
(95% CI, -0.11 to 
-0.99) 
 
DV2= ↓ SBP 
(∆=-5.2mmHg 
(95% CI, -3.0 to -
7.4)  
 
DV3= (∆=-6.6 
mg/dl) (95% CI 
2.8 to -16.1) LDL 
↓ but not 
statistically 
significant  
 
A1C result had 
significant 
heterogeneity 
among studies.  
 
Weakness: 
• Heterogenicity among the 
components of diabetes SMAs 
leads to uncertainty about what 
makes a particular SMA 
successful 
Strengths: 
• Systemic review with meta-
analysis of RCTs and 
observation studies  
• Level 1 evidence  
Conclusion: 
• SMA improved biophysical 
outcomes among patients with 
T2DM.  
•  Inadequate data to determine 
the effect on PT experience, 
utilization and cost. 
 
Risk/Benefits: Benefits outweigh risks 
 
 Recommendations: 
• SMA is feasible in practice  
• Level I evidence, will 
recommend as the standard of 
care  
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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MM, DSME, PS 
 
# of PT per 
session: 
6-10 (n=10) 
10-20(n=5) 
25 (n=1) 
 
Visit frequency: 
3 weeks -3 
months  
 
Duration: 
medical of 2 
hours (range 1 
to 4hr) 
 
Staff: 
MD (n=13) 
Pharmacist 
(n=9) 
Nurse (n=10) 
 
  
lead 17 
studies  
 
 Poor 
glucose 
control 
(from 
A1c6.5-9%) 
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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Housden et 
al,(2013) 
Effectiveness of 
SMA for 
improving DM 
care: a SR and 
meta-analysis. 
Cana. Med. 
Asso. Journal, 
185(13). E635-
E64.  
 
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 SR and meta-
analysis of the 
evidence on 
effectiveness 
of SMA for 
patients with 
DM  
None  SR of RCT and 
observational 
studies.   
 
Meta-analysis 
studies 
published 
between 1947 to 
February 2012.   
 
Literature 
search was 
conducted using 
MEDLINE, 
CINAHL ect,. 
 
94studies 
identified 26 
selected, 13 
were RCT 
N=28 ,347 
identified 
through 
database 
search,  
 
n=92(abstrac
t + title 
review)  
 
n=62 
(articles 
identified for 
full text 
review)  
 
n=36 
(studies 
excluded 
after full text 
review)  
 
n= 26 
(studies that 
was 
selected) 
 
n= 13 ( 
RCT) 
IV: SMA 
 
DV:  
 
DV1:Hgb 
A1c 
DV2: BP 
DV3: 
Cholesterol  
DV4: Weight  
DV5: BMI  
Weighted 
mean 
difference  
 
% reduction in 
A1C 
Data 
from 
RCT was 
analyzed 
using 
Review 
Manager 
software 
(RevMan
. Version 
5.1 
Nordic 
Cochran
e center). 
A X2 for 
heteroge
nicity 
was 
used. 
 
DV1=PTs 
attending SMA 
(weighted mean 
difference (-
0.46%, 95% CI -
0.80 to -0.31)  
 
DV2= -2.81%, 
95% CI (-6.84 to 
1.21) 
 
DV3: 0.04%, 
95% CI (-0.21 to 
0.30) 
 
DV4:-0.50%, 
95% CI ( -3.87 to 
2.88) 
 
DV4: 0.05%, 
95% (-0.90 to 
1.00) 
Weakness:  
• Few long-term studies in the 
review. 
• Search restriction to published 
studies only 
• Articles written in English only 
were included  
Strengths: 
• Systemic review of RCT and 
observational studies  
• Level I evidence  
Conclusion: 
• SMA reduced hemoglobin A1C 
for T2DM.  
• Wider implementation of SMA 
will have positive impact on 
patient outcomes. 
 
 
Risk/Benefits: Benefits outweigh risk  
 
Recommendation:  
• SMA should be implemented 
in practice to improve 
outcomes for T2DM PT 
• SMA is feasible in practice  
• Level I evidence, we should 
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
 
 
Citation: 
author(s), date 
of publication& 
title 
Purpose of 
Study 
Concept
ual 
Framew
ork 
Design/ 
Method 
 
Sample/ 
Setting 
Major 
Variables 
Studied and 
Their 
Definitions 
 
Measurement 
of Major 
Variables 
Data 
Analysis 
 
Study Findings 
Appraisal of Worth to Practice 
Strength of the Evidence (i.e., level of 
evidence + quality [study strengths and 
weaknesses]) 
RECOMMENDATIONS 
 use this as the standard of 
care. 
Ridge, T. (2012) 
shared medical 
appointment in 
diabetes care: A 
Literature 
review.  
Diabetes 
Spectrum, 25 
(2), 72-75. 
 
 
 
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
Literature 
review of RCT 
and non-RCT 
studies  
None Evidence 
review, how the 
studies were 
chosen was not 
stated 
7 RCT , and 
2 non RCT 
were 
included in 
the review. 
Variables 
reviewed in 
the studies: 
 
 
IV; SMA 
 
DV: Hgb A1c 
Not stated  Not 
stated 
The review of the 
different studies 
concluded that 
SMA was 
effective in 
reducing HgbA1c 
 
Weakness: 
• Level VII evidence  
Strength 
• RCTs included in the review 
 
 
 
• Conclusion: SMA have 
demonstrated effectiveness in 
improving knowledge, quality 
of life, and problem-solving 
skills related to diabetes 
 
 
. Risk/Benefits: Benefits outweigh risk  
 
Recommendation:  
• Level VII evidence, but in 
agreement with higher level 
studies, 
•  Will recommend with caution  
as the standard of care  
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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Berry et al, 
(2016). 
Imbedding 
interdisciplinary 
diabetes GV into 
a community-
based medical 
setting. The 
DEr, 42 (1), 96-
107.  
 
 
 
 
 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 To evaluate 
an 
interdisciplinar
y approach  
and test the 
efficacy of 
diabetes SMA 
tailored to 
low-income 
PTs in a  
community 
based medical 
practice  
 
 
None  RCT 
 
• Method: 
Intervention 
group -5 
diabetes SMA 
sessions, 1 
every 3 months 
X15 months   
 
Control group 5 
individualized 
sessions, 1 
every 3 months 
X 15 months 
with PCP.  
 
Intervention 
SMA method: 
 
# of PTs per 
SMA session: 
40 
 
Duration: Not 
stated 
 
Program: 
N=80 
n=40 Pts for 
intervention 
group 
n=40 control 
group 
 
Inclusion 
criteria: 
 
• age: 18 <,  
• speak, read 
and write 
English, 
• primary 
care from 
Alliance 
Medical 
Ministry,  
• A1c > 8%. 
 
Setting: 
Clinic 
(Alliance 
medical 
ministry)  
 
Attrition: 12 
IV1 : SMA 
 
IV2: IMA 
 
DV1: 
HgbA1c 
 
DV2: Lipids  
 
DV3: BP 
 
DV4: HR  
DV1: % 
reduction 
DV2: % 
reduction 
DV3: mean 
reduction  
Dv4: mean 
reduction 
p-value  DV1= 
Intervention 
group A1C ↓ by 
1.2% to 7.6% 
(p=0.001);   
 
Pts in the control 
group ↑ their A1c 
by 1.3 percentage 
pts to 9.3% at 
time 5. 
 
DV2= Lipids ↓ in 
intervention 
group 
HDL(P=0.033), 
Triglycerides 
(p=0.033) 
 
DV3= BP ↓ by 
time by 
time5(15months) 
 
DV4=HR ↓ by 
time 5 (15 
months) 
(p=0.031) 
 
Weakness:  
• Single site study 
Strengths: 
• Level II evidence  
• Ethnic diversity 
 
Conclusion: 
• Diabetes group visits which 
included DSME and a medical 
visit with healthcare provider 
improved A1C.  
 
 
Risk/Benefits: Benefits outweigh risks 
 
Recommendation:  
• SMA is feasible and practical to 
implement is practice 
• SMA can be implemented to 
help ethnically diverse low 
income working full time PT to 
improve A1C 
• Level II evidence that agrees 
with higher level studies 
• Will recommend as the 
standard of care  
 
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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15 months  
 
Staff: 
NP 
MD 
Nurse  
Dietician  
Exercise-
educator 
Clergy  
 
DSME 
curriculum: 
Diabetes 
Foot care 
BGM 
Blood pressure 
Lipids  
Nutrition 
Exercise  
Complications  
 
SMA technique: 
MM 
individually 
DSME and PS 
in group 
 
(finding from 
study, HR was 
never elevated) 
 
 
 
 
 
 
 
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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Guthrie et al, 
(2015). Impact 
of a SMA life 
style 
intervention on 
Wt and lipid 
parameters in 
individual with 
T2DM: A 
clinical pilot. 
Journal of 
Amer. Coll. of 
Nut., 34 (4) 300-
309.  
 
 
 
USA 
 
 
 
 
 
 
 
 
To evaluate 
the 
effectiveness 
of a DM 
educational 
program 
combining 
SMA with 8 
week DVD 
based DM 
education 
program 
emphasizing a 
plant based 
diet in 
lowering Wt. 
and lipids in 
individuals 
With T2DM 
 
 
 
 
 
 
 
 
 
None A pilot 
nonrandomized 
own-control 
study  
 
Method: 
Procedures: 
16 SMA 
sessions  
 
Intervention: 
SMA method:  
 
Duration: 90-
120 minutes  
 
Program: SMA 
with 8week 
biweekly DVD 
video DSME 
 
Staff:  
Medical 
provider, 
Resident  
 
DSME video 
presenters(MD, 
dietician, 
Non- 
randomized 
convenience 
sample  
 
Own-control 
 
N= 46 
participated 
in the WSDP 
program. 
 
Attrition: 
N=2  
 
Setting: 
Clinic ( 
Family 
medicine 
practice in 
Orlando, 
FL). 
IV: SMA with 
DVD video 
DSME 
 
DV:  
 
DV1: 
Cholesterol 
 
DV2: LDL 
 
DV3: HDL 
 
DV4: 
Triglycerides  
 
DV5: Weight  
DV1: MC 
DV2: MC 
DV3: mean 
changes 
DV4: MC 
DV5: MC 
 
Paired t-
test 
DV1= Total 
cholesterol ↓ (-
6.20mg/dl) t= 
1.01 
 
DV2=LDL ↓ (-
6.43mg/dl) t=1.31 
 
DV3=HDL= ↑ (-
1.98mg/dl) t=1.55 
 
DV4= 
Triglycerides ↓ (-
-2.39mg/dl) 
t=0.24 
 
DV5= Weight ↓ 
Significantly 
(mean of -8.90lb) 
t=7.05, p<0.05) 
 
Improvements 
seen in LDL, 
HDL, cholesterol 
and triglycerides, 
but did not reach 
statistical 
significance. 
Weakness: 
• A pilot study 
• Convenient sample  
• No randomization 
• No control group 
• Small sample size 
Strength: 
• Level III study 
• Measured variables improved  
 
Conclusion: 
• DVD based DSME delivered as 
part of SMA was associated 
with significant Wt. loss.  
• Behavior changes most closely 
associated with weight loss 
were ↑ water intake, 
eliminating evening meals, and 
increasing the consumption of 
beans for breakfast. 
 
Risk/Benefits: Benefits outweigh risk  
 
Recommendation:  
• Level III evidence, agrees with 
higher level studies  
• Will recommend as the 
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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exercise 
physiologist) 
 
# of PT per 
session: Not 
stated  
 
Video DSME 
curriculum: 
Exercise  
Nutrition 
Diabetes  
 
SMA technique: 
MM, PS, 
DSME(video) 
 
standard of care.  
 
Note: 
SMA session flow  
 
Vital signs, behavior reporting form 
completion =10 t0 15 minutes 
 
 DVD video lecture. Exercise, and 
nutrition, and diabetes management: Data 
recorded in the EMR= 45 to 50 minutes  
 
Questions and answer session= 10 
minutes  
 
Shared medical appointment with each 
participant= 45 to 60 minutes  
Liu et al., 
(2012). Effe. Of 
using SMA to 
sup. DM PT 
self-mgt in rural 
comm. Of 
Shanghai> RCT. 
BMC Pub 
Health 12, 1043 
 
 
 
 
 
 
To develop 
SMA program 
and examine 
its 
effectiveness 
on SMB, SE, 
HS for PT 
with T2DM. 
The 
Coopera
tive 
Health 
care 
Clinic 
model 
RCT. 
 
Intervention(n=
119) 
 
Control(n=89) 
IMA for 12 
months  
 
SMA Method: 
Intervention:  
 
Program: 
12 SMA 
sessions for 12 
N=208 
 
I-(n=119) 
 
C-(n=89) 
Inclusion- 
men and 
women 35-
80 with 
T2DM 
 
Exclusion- 
age <35 and 
>80 
 
IV1: SMA 
 
IV2: IMA 
 
DV1: SMB 
DV2: SE 
DV3: HS 
DV3a: SBP 
DV3b: BMI 
SMB-
questionnaire 
 
SE-SE Chinses 
version of 8 
item DM Se 
scale 
developed by 
Stanford 
patient 
education 
research center    
 
HS- 
Questionnaire  
MC  
SD 
P value 
DV1: ↑ Aerobic 
exercise by > 40 
minutes per 
week(P=0.001) 
 
DV2: 
Intervention 
group ↑ of 0.71 in 
mean SE 
score(p=0.02) 
 
DV3: 
Intervention 
group had 
significant 
Weakness: 
• Mostly older patients with 
higher prevalence of disease  
• 15% of subjects did not 
complete the study 
• Small sample size  
Strengths: 
• RCT 
• Lasted 12 months  
 
Conclusions:  
•  Chines diabetes SMA model 
was feasible acceptable and 
effective alternative for 
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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months X 
monthly 
 
Duration: 1.5 
hours  
 
Staff:  
Provider 
Nurse  
 
DSME 
curriculum:  
Diabetes  
Nutrition 
Exercise  
Foot care  
Medication 
 
SMA technique: 
MM separated 
from group. 
DSME and PS 
 
Setting: 
Rural area in 
Shanghai  
 
Attrition: 
I=21:  
 
moved out 
(n=10) 
 
Died(n=3) 
 
Refused 
(n=2) 
 
Unknown 
(n=6) 
 
C=11: 
moved out 
(n=4) 
 
Died(n=2) 
 
Refused 
(n=3) 
 
Unknown 
(n=2) 
 
 
improvement in 
measures of 
illness and SBP.  
 
DV3a=3.72mmH
g ↓ on average. 
(p=0.04)  
 
DV3b= ↓ 
0.28kg/m^2 
(P=0.22) 
providing self-management 
support to PT with T2DM in 
Chines rural communities  
 
Risk/Benefits: Benefits outweigh risk  
 
Recommendation: 
• This model of SMA is feasible 
and should be implemented in 
practice to improve diabetes 
outcomes 
• Level II evidence that agrees 
with higher level I evidence  
• Will recommended with 
caution because the study did 
not measure A1C. More 
information is needed  
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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Cole et al., 
(2013) Eff. Of 
prediabetes 
nutria. SMA. 
Diab. Edu. 
39(3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To evaluate 
nutrition based 
SMA 
intervention in 
treatment of 
prediabetes 
compared to 
individualized 
counseling  
None  RCT 
Nutrition 
SMA(I), and 
individualized 
counseling (C) 
 
Method: SMA 
group attended 
three 90 minutes 
nutrition SMA, 
 
 Control group 
attended 60 
minutes IMA 
registered 
dietician.  
 
SMA method: 
Nutrition based 
SMA  
 
Duration: 1.5 
hours  
 
Program: 
Monthly SMA 
X3 months  
 
# of PT per 
session: 6-8 
 
 
N =94 
 
I-(n=34) 
 
C-(n=31) 
 
 
Inclusion: 
≥18 years of 
age, English 
speaking and 
Dx of 
prediabetes  
 
Exclusion: 
Dx of 
diabetes  
 
Setting: 
Enrollees of 
TRICAR 
health care 
system  
 
Attrition: 
n=29 
IV: Nutrition 
SMA 
 
DV1: FBG 
DV2: A1C 
DV3: WT 
DV4: BMI 
DV5: BP 
DV6: 
Cholesterol  
  
FBG- MC 
A1C- MC 
Wt- MC 
BMI- MC 
BP- MC 
 
Mean ± 
SD 
ANOVA 
 
Outcome at 3 
months compared 
to baseline:  
 
Repeated 
measures 
ANOVA within 
group (P<0.05) 
 
SMA(n=34) 
DV1: -6±9 
 
IMA (n=31) 
DV1:-6±15 
 
SMA(n=34) 
DV2: (0.1±0.4) 
 
IMA (n=31) 
DV2: 0.4± 1.1 
 
SMA (n=34) 
DV3: -3.0± 3.0 
 
IMA (n=31) 
DV3 -1.6± 3.3 
 
SMA (n=34) 
DV4: -1.0±1.1 
 
IMA (n=31) 
DV4: -6.6± 1.2 
Weakness:  
• High attrition rate  
Strengths: 
• RCT 
• Long duration  
 
Conclusion: 
• SMA outcomes yielded a 
greater degree of 
improvements than the control 
group 
• SMA is equivalent to individual 
appointment to support 
hypothesis  
 
 
Risk/benefits: Benefits outweigh risk  
 
Recommendation:  
• SMA is feasible and should be 
available in practice as an 
alternative for patients  
• SMA should be implemented in 
practice to improve outcomes 
• Level II study that agrees with 
higher level study  
• Will recommended as the 
standard of care   
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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Staff:  
Dietician  
DE 
Nurse 
Behavioral 
specialist  
 
DSME 
curriculum:  
Nutrition 
Exercise   
 
SMA technique: 
MM, DSME, PS 
SMA (n=34) 
DV5: SBP -
12±16 
 
IMA (n=31) 
DV5: -12±17 
 
SMA (n=34) 
DV6: -14±41 
 
IMA (n=31) 
Dv6: -6±24 
Cohen et 
al.,(2011). 
Pharmacist-led 
SMA for multi. 
Cardio. Risk 
reduction in PT 
with T2DM. The 
Diabetes 
Educator,37(6) 
To assess 
whether VA 
MEDIC-E, a 
pharmacy led 
SMA program 
could improve 
outcomes 
compared to 
individual 
appointment  
None RCT 
 
I-=VA MEDIC-
E(SMA) 
 
C= (IMA) 
 
SMA Method: 
 
Duration: 2 
hours  
 
Program: 
SMA (VA 
MEDIC-E)  4 
once weekly 2 
hour sessions, 
followed by 5 
N=99 
VA MEDIC-
E(SMA) 
n=50 
 
Individual 
apt (Control 
) n= 49 
 
Inclusion: 
DX of 
T2DM, A1C 
> 7%, LDL 
>100,BP 
>130/80 
 
Setting: 
Clinic, VA 
IV: Va 
MEDIC-
E(SMA) 
 
DV1; A1C 
DV2: LDL 
DV3: SBP 
 
A1C- % 
reduction 
LDL- MC 
SBP- MC 
  
Mean  
SD 
t-test 
percent  
DV1: MEDIC 
arm achieved 
target A1C values 
(40.8% vs 20.4% 
in control 
(p=0.028) 
 
DV2: MEDIC 
arm had ↓ of LDL 
96.1mg/dl vs 
110.7mg/dl in 
control (p=0.024) 
 
DV3: SBP 
<130mmHg (58% 
cases vs 32.7% 
control) 
(p=0.015) 
Weakness:  
• Mostly male veterans 
• Mostly Caucasians   
• Names of some of instrument 
not stated  
Strengths 
• RCT 
• Multi-displenary  
 
Conclusions: 
• Pharmacist led SMA was an 
efficacious and sustainable  
• A collaborative care approach 
to managing diabetes to 
reduce cardiac risk. 
 
 
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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monthly booster 
sessions. 
 
Staff:  
Pharmacist(prov
ider) 
Dietician  
Nurse  
 
DSME 
curriculum:  
Diabetes  
Medication 
Stress 
Nutrition 
Exercise  
Foot care 
 
# of PT per 
session: 4-6 
 
SMA technique: 
MM, DSME, PS 
 
IMA group 
attended once 
every 4 month 
visits  
 
 
medical 
center  
 
Attrition n=3 
Died(n=3) 
 
At 6 months, 
significant 
improvements 
from baseline 
were noted in the 
VA MEDIC-E 
group for 
exercise, foot 
care and goal 
attainment of 
A1C, LDL, and 
BP, but not in the 
control group 
 
Risk/Benefits:  Benefits outweigh risk  
 
Recommendation:  
• Level II evidence and Supports 
the findings of level I evidence. 
•  Will recommended as 
standard of care  
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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Tokuda et 
al.,(2016). The 
Utili. Of video-
conference 
SMA in rural 
diabetes care. 
Inter. Jour. Of 
Medical 
Informatics,93. 
To explore the 
feasibility of 
innovative 
modes of care 
delivery such 
as video-SMA 
to improve 
DM care at 
remote clinical 
site 
None Prospective 
non- 
randomized 
study 
 
SMA Method: 
Intervention: 
 Weekly video  
SMA for 4 
weeks, followed 
by bi-monthly 
booster for 5 
months  
 
Duration: 2 
hours  
 
# of PT per 
session: 3-5 
 
Staff:  
NP 
Pharmacist 
 
DSME 
curriculum: 
Nutrition 
Exercise  
Medication 
Diabetes  
BM 
 
N=100 
 
Intervention(
n=31) 
 
Control(n=6
9) 
 
Inclusion: 
A1C ≥ 7% 
 
 
Setting: rural 
community 
outpatient 
clinic  
 
Attrition: 
NR 
IV: Video 
SMA 
 
DV1: A1C 
DV2: BP 
DV3: LDL 
DV4: 
Triglycerides  
AIC-% 
reduction,  
BP- MC 
Mean 
±Standar
d Error  
DV1:  Greater ↓in 
A1C was 
observed in SMA 
group after 1 to 3 
months 9.1 ± 0.3 
to 8.3 ± 0.3  vs 
IMA 8.6 ± 0.2 to 
8.7 ± 0.2 (p=0.03) 
 
DV2: SMA group 
had significant ↓ 
in both DBP and 
SBP than control 
(p=0.04 and 
p=0.01, 
respectively) 
 
DV3: Baseline 
2.4 ± 0.2 vs 5 
months, 2.2 ±0.2 
(p=0.55) 
 
DV4: Baseline: 
2.6 ±0.7 vs 5 
months 2.1 ± 2.3 
 
patients in video 
SMA group 
showed lower 
rate of ED visits 
relative to the 
control group 
Weakness:  
• No randomization  
• Mostly men  
• Small sample size  
Strengths  
• Quasi experimental study  
• A1C significantly ↓ 
Conclusion: 
• Video -SMA is feasible, well 
perceived and has the 
potential to improve diabetes 
outcomes in a rural setting.  
 
Risk/Benefits: Benefits outweigh risk  
 
Recommendation:  
• Level III evidence that agrees 
with level II studies  
• Will recommend as the 
standard of care  
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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Taveira, et 
al.,(2011). 
Phamarcist-led 
SMA for mgt of 
DM with 
comorbid 
depression Ann. 
of 
Pharmacotherap
y,  
The study 
sought to 
determine 
whether SMA 
are feasible for 
the tx of DM 
in patients 
with 
depression 
None RCT 
I=(VA-MEDIC-
D)(SMA) 
 
C=(IMA) 
 
Method: 
Program: 
SMA VA-
MEDIC-D 
attended 4 once 
wkly SMA, 
followed by 5 
monthly booster 
sessions  
 
Duration:2 
hours 
 
# of PT per 
session: 4-6 
 
  
N=88 
 
I=VA-
MEDIC-D 
(n=44) 
 
IMA= 
(n=44) 
 
Inclusion:  
Veterans 
with type 1 
or type 2 
DM with 
A1C >6.5 
within the 
last 6 month 
 
  
Setting: 
Outpatient 
clinic 
 
IV= VA-
MEDIC-D 
 
DV= IMA 
(standard 
care) 
 
DV1:A1C 
DV2: BP 
DV3: Lipids  
DV4: 
Depression 
AIC-
Proportion of 
pt at goal  
BP- MC 
Depression- 
PHQ-9 scale 
Proportio
n of pt 
who met 
A1C 
goal 
 
OR 
PHQ-9 
Mean 
DV1:  
 The VA-
MEDIC-D arm 
achieving 
guideline 
adherence for 
A1C was > IMA 
(29.6% vs 11.9%) 
with OR 3.3(95% 
CI 1.0 to 10.0) 
(p=0.04) 
 
DV2: BP ↓(IV 
mean 
123.4mmHg vs 
IMA mean 
127mmHg(p=0.1
0) 
DV3: IV mean 
LDL=92.5mg/dl 
vs IMA mean 
93.9mg/dl) 
Weakness: 
• Single site homogenous 
population 
• Small sample size 
Strengths: 
• RCT 
• Duration of SMA longer than 
most 
Conclusion: 
• Pharmacist led group SMA 
visits are efficacious in 
attainment of glycemic control 
in patients with diabetes 
• It improved depression 
symptoms  
 
Risk/Benefits: Benefits outweigh risk 
 
Recommendation:  
• Level II evidence that agrees 
with level I evidence findings  
• Will recommend as standard of 
 Legend: BDI=Beck Depression Inventory; BP= Blood pressure; BGM= Blood Glucose Monitoring: BS=blood sugar; BMI=Body Mass Index; BM; Behavioral modification; CM= cardiovascular 
morbidity; CHOL=Cholesterol; CG=comparison group; C=Control group; CBOC=community based outpatient clinics; DSME=diabetes self-management education ;DM= Diabetes Mellitus; DS= 
disease severity; DSI=diabetes severity index; DX= Diagnosis; DBP= diastolic blood pressure; DESSF=Diabetes Empowerment Scale Short Form; DV=dependent variable; DE=Diabetes Educator; 
EMR=electronic medical records; FBG=Fasting Blood Glucose; GC=glycemic control; HS=Health Status; HDL=High Density Lipoprotein; Hx=History; Hgb A1c= hemoglobin A1c; IV= Independent 
variable; I=Intervention group; IMA=Individual Medical Appointment; LSM=Life Style Modification; LRM= linear regression model;  LDL= low density lipoprotein; MR= mean reduction; 
MU=medically underserved; MA=Medical Assistant; MC=medical center; MR=Mean reduction; MC=Mean change; MD=Medical doctor; MM=medical management; NPCT=nurse practitioner 
coordinated team; NR=not reported; NP=nurse practitioner ; OPC=Out Patient Clinic; OR= odd ratio; PS=Peer support; PC= primary care; PCP=Primary care provider; PT=patients; RCT=randomized 
controlled studies; Rx=Prescription; SMA= shared medical appointment; Seattle Outpatient Satisfaction Questionnaire ;SBP=systolic blood pressure; SR=systemic review; SD=Standard Deviation; 
SMB=Self-management behaviors; SE= self-efficacy; T2DM= type 2 diabetes mellitus; TC=Total Cholesterol; TTM: Trans theoretical Model of Change; TG=Triglycerides; Wt.= weight; 
UMDRTC=university of Michigan diabetes research training  center; UC= usual care; VA=veterans affairs; ↓=Decrease; ↔ Not statistically significant. 
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SMA technique  
MM, DSME, PS 
 
IMA arm 
attended regular 
visit with PCP 
for 30 minutes  
with DSME 
available to 
them 4 once 
weekly for 2 
hours  
 
Attrition: 2 
lost to f/u, 1 
died and 1 
nursing 
home (hip 
fx) 
 
 
DV4: PHQ-9 
score ↓ by 
50%from 
baseline for 
45.5% of VA-
MEDIC-D group 
and 34.1% for 
IMA 
group(p=0.28) 
care  
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Appendix C: Synthesis Tables 
Table B  
   Level of Evidence of the Research Studies  
                                                             
  
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
       11 
 
     12 
 
      13 
 
      14 
 
     15 
Level I: Systemic 
review or meta-
analysis 
      
   ✓     
 
✓ 
        
 
Level II: 
Randomized 
controlled trial 
         
 
✓ 
 
  
 
        ✓ 
 
 
       ✓ 
 
 
       ✓ 
  
 
      ✓ 
Level III: controlled 
trial without 
randomization 
    
✓ 
   
✓ 
 
✓ 
 
✓ 
 
 
     
     ✓   
    
       ✓ 
 
 
Level IV: Case-
control or cohort 
study 
     
✓ 
      
          
 
Level V: Systemic 
review of qualitative 
or descriptive study  
               
Level VI: 
Qualitative or 
descriptive study 
(includes evidence 
implementation 
projects) 
 
 
 
 
 
 
        
 
     
 
Level VII: Expert 
opinion or consensus  
        
✓ 
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Table C   
   Effect of Shared Medical Appointment on Patient Outcomes 
 
 
 
 
  
 
 
 
 
 
 
1 2 3 4 5 6 7 8 9 10       11      12      13       14      15 
 
Hemoglobi
n A1C 
 
↓ 
 
↓ 
 
↓ 
 
↓ 
 
↓ 
 
↓ 
 
 ↓ 
 
↓ 
 
↓ 
   
      ↓ 
 
      ↓ 
 
        ↓ 
 
       ↓ 
 
Lipids  
      
↓ 
   
↔      
  
↓        
    
↓         
 
  ↓ 
  
       ↓ 
   
       ↓ 
        
 
Blood 
Pressure 
       
↓ 
   
 ↓ 
   
↓         
   
↓        
  
        ↓ 
 
       ↓ 
 
       ↓ 
 
        ↓ 
 
       ↓ 
 
Weight  
       
↓ 
   
↔ 
        
   ↓ 
  
        ↓ 
   
 
Knowledge  
   
 
↑ 
     
 
↑ 
   
 
       ↑ 
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Table D  
   SMA duration and frequency         
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
1 2 3 4 5 6 7 8 9  10     11      12      13       14     15 
 
How Often? 
 
 
Monthly 
 
 Weekly Weekly  3 week 
to 3 
months 
Varied  Q 3 
months  
Biweekly Monthly Monthly  WeeklyX4 
Then, 
Monthly 
boosterX5 
WeeklyX4, 
then, 2 bi 
monthly 
booster 
 
Weekly 
X4, then 
monthly 
booster 
X5 
How many 
minutes per 
SMA 
session? 
 
2hours  4hours 3 hours 90 
minutes 
1 to 4 
hours  
2 hours 
Average  
  2 hours 1.5 
hours 
90 
Minutes 
2 
Hours 
 
         1.5 
        Hours 
 
   2  
hours 
Total 
Duration of 
SMA 
intervention  
 
 
3  
Months 
 3  
weeks 
4 
weeks 
 Varied 4 
months 
to 4 
years  
 15 
months  
8  
weeks  
 12 
Months  
    3 
Months 
 
   6 
Months 
 
      5 
  Months 
     6 
Months 
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Table E 
   SMA Diabetes Curriculum 
 
Diabetes 
self-
management 
strategies  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
 
Medication 
Management  
 
 
√ 
  
 
√ 
  
 
√ 
    
 
√ 
  
 
√ 
  
 
√ 
 
 
√ 
 
 
   √ 
 
Nutrition 
management  
 
√ 
  
√ 
  
√ 
    
√ 
 
√ 
 
√ 
 
√ 
 
√ 
 
√ 
 
   √ 
 
 
Exercise  
 
 
√ 
  
 
√ 
  
 
√ 
    
 
√ 
 
 
√ 
 
 
√ 
  
 
√ 
 
 
√ 
 
      
      
 
Behavioral 
modification 
 
 
√ 
  
 
√ 
  
 
√ 
    
 
√ 
 
 
√ 
 
 
√ 
  
 
√ 
 
 
√ 
 
 
   √ 
 
Foot care  
 
√ 
  
√ 
        
√ 
  
√ 
  
Diabetes 
overview  
   
√ 
  
√ 
    
√ 
  
√ 
  
√ 
 
√ 
 
   √ 
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Table F 
SMA Logistics  
 
SMA 
Logistics 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Synthesis  
Primary  
Care  
✓ ✓ ✓ ✓     ✓ ✓ ✓ ✓ ✓ ✓ ✓ 12/15 
 
Group 
Support 
✓ ✓ ✓ ✓     ✓ ✓ ✓ ✓ ✓ ✓ ✓ 12/15 
 
DM Self-
management  
education 
✓ ✓ ✓ ✓     ✓ ✓ ✓ ✓ ✓ ✓ ✓ 12/15 
 
How many 
patients per  
Group session 
 
4-20 
  
11 
  
8-15 
      
20-25 
 
6-8 
 
4-6 
 
4-6 
 
4-6 
4-6= 3 
20-25=1 
6-8= 1 
8-15= 1 
11= 1 
4-20= 1 
Inter-
professional  
Team 
                
 
Nurse  
 
✓ ✓ ✓ ✓     ✓  ✓ ✓ ✓ ✓ ✓ 11/15 
 
Medical 
Provider 
✓ ✓ ✓ ✓     ✓ ✓ ✓ ✓ ✓ ✓ ✓ 12/15 
 
Dietitian 
✓ ✓       ✓   ✓   ✓ 5/15 
 
Counselor 
  ✓         ✓    2/15 
 
Exercise  
Trainer  
        ✓       1/15 
 
Health 
Psychologist 
    ✓           1/15 
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Appendix D: Match of Plan to Evidence 
Table G 
   Match of Plan to Evidence 
 
Intervention 
 
Evidence  
 
Baseline data will be collected pre/post 
 
 
1,2,4 
 
SMA will include medical management, peer support and DSME 
 
 
1,2,3,4,5,9,10,11,12,13,14,15 
 
SMA will be held weekly x4 then booster x2 
 
 
3,4,13,14,15 
 
SMA will last 2 hours/session with intervention duration of 3 
months 
 
 
1,7,10,12,13,15 
 
DSME curriculum will include: medication management, 
nutrition, exercise management, foot care, diabetes overview and 
behavior modification 
 
 
1,3,5,9,10,11,13,14,15 
 
SMA groups per session will include 4-6 patients 
 
 
1, 13,14,15 
 
The inter-professional team will include at least a medical 
provider and a nurse 
 
 
 
1,2,3,4,5,9,11,12,13,14,15 
 
Outcome measure will include A1C, BMI, Lipid values, and 
knowledge 
A1C-
1,2,3,4,5,9,11,12,13,14,15 
 
Lipid values- 
1,4,6,9,10,12,15 
 
BP- 1,4,6,9,11,12,13,14,15 
 
Weight- 1,4,10,12 
 
Knowledge- 3,8,11 
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Appendix E: Intervention Plan 
Table H  
   Intervention Plan 
 
When-  
Date  
 
Who What Where How  
January 19th, 
2018/ 
Week 0 pre-
implementation 
NP 
Registered 
Nurse (RN) 
Medical 
Assistant 
(MA) 
Staff education/In-service  Clinic nurses 
station  
• Presentation, 
• Logistics/protocol 
discussion, 
• Mock SMA 
• Resource review  
• SMA schedule review 
 
March 23rd, 
2018/Week 1 
implementation 
MA • Patient 
registration 
Receptionist desk Using EPIC EMR 
 RN • Vital signs 
including 
weight and BP 
 
Group room Using Welch Allyn Dinnamap 
 NP • Baseline data 
collection ( 
A1C, BP, Lipid 
values, 
Knowledge ) 
 
Group room 
 
 
 
 
 
 
 
A1c, BP, Lipid values, queried from 
EPIP EMR and transferred to Excel 
sheet  
 
Knowledge test was administered 
using University of Michigan 
Diabetes Research Training 
Center(UMDRTC) diabetes 
knowledge test 
 NP • Patient chart 
review  
Provider office  Going through each chart one by 
one 
 Patients, NP, 
RN, MA 
• Introduction and 
Ice breaker 
session  
Group room Each staff introduced him/herself 
and each patient did the same. 
HIPPA reminder was discussed 
during this session 
 NP • Medical 
management   
Group room NP sequentially attended to each 
patient in the group starting with 
brief medical history first, followed 
by brief physical examination and 
finally, discussion of the lab results 
including hemoglobin A1C and 
medication management with the 
participation of the group as peer 
support. This lasted 5-10 minutes 
per patient  
 NP 
RN 
• Diabetes Self-
Management 
Education 
(DSME)  
Group room Presentation using, pictures, 
handouts, and cards. Topic included: 
Diabetes overview(basics) including 
pathophysiology, acceptable lab 
values for A1c, hypoglycemia, 
glucose monitoring and 
complications; medication 
management, nutrition management, 
exercise, foot care and behavioral 
modification Week 1 education 
focused on diabetes overview: 
Pathophysiology, and acceptable 
values for A1C. ADA professional 
resources handouts on diabetes 
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When-  
Date  
 
Who What Where How  
pathophysiology and A1C was 
utilized. The mode of delivery was 
discussion/demonstration/handouts. 
This lasted for 60 minutes  
 NP 
RN 
Patients 
• Peer support in 
the group  
Group room  Patients asked questions, and they 
were also shared their success 
stories with their peers in the group. 
Patients who were doing well with 
meeting their glycemic goals were 
praised and were encouraged to lead 
the discussion and educate those 
who are struggling with meeting 
their glycemic targets. Peers 
provided support as necessary. This 
lasted for 30 minutes  
 NP • Visit conclusion 
and goals   
Group room The session ended with each patient 
setting a clear achievable goal as to 
how they plan to improve their 
diabetes management before next 
meeting by writing the goal down 
on a paper. The session was 
adjourned until next week Thursday. 
March 29th, 
2018/Week 2 
MA • Patient 
registration  
Receptionist desk  Using EPIC EMR 
 RN • Vital signs 
including 
weight and BP 
Group room Using Welch Allyn Dinnamap 
 
 NP • Patient chart 
review  
Provider office  Going through each chart one by 
one  
 Patients, NP, 
RN, MA 
• Introduction and 
Ice breaker 
session 
Group Room Each staff introduced him/herself 
and each patient did the same. 
HIPPA reminder was discussed 
during this session 
 NP • Medical 
management  
Group room  NP sequentially attended to each 
patient in the group starting with 
brief medical history first, followed 
by brief physical examination and 
finally, discussion of the lab results 
including hemoglobin A1C and 
medication management with the 
participation of the group as peer 
support. Each patients progress was 
discussed in the group. Peers 
provided support as necessary. This 
lasted 5-10 minutes per patient 
 NP 
RN 
• DSME Group room Presentation using, pictures, and 
handouts. Week 2 education focused 
on Diabetes overview: 
hypoglycemia and glucose 
monitoring. American Diabetes 
Association (ADA) professional 
resource handouts on hypoglycemia 
and glucose monitoring. Defining 
what is hypoglycemia? What can 
you do to avoid it? What are the 
signs and symptoms of 
hypoglycemia? What are the 
complications of hypoglycemia? 
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When-  
Date  
 
Who What Where How  
What types of food can you eat to 
avoid hypoglycemia? This lasted for 
60 minutes 
 NP  
RN 
• Peer support in 
the group 
Group room Patents asked questions, and they 
were also encouraged to share their 
success stories with their peers in 
the group. Patients who are doing 
well with meeting their glycemic 
goal were praised and were 
encouraged to lead the discussion 
and educate those who are 
struggling with meeting their 
glycemic targets. This lasted for 30 
minutes 
 NP • Visit conclusion 
and goals   
Group room  The session ended with each patient 
setting a clear achievable goal as to 
how they plan to improve their 
diabetes management before next 
meeting by writing the goal down 
on a paper. The session was 
adjourned until next week Friday. 
April 6th, 
2018/Week 3 
NP • Patient 
registration  
Receptionist desk  Using EPIC EMR 
 RN • Vital signs 
including 
weight and BP 
Group Room Using Welch Allyn Dinnamap 
 NP Patient chart review Provider Office  Going through each patient chart in 
EPIC EMR 
 Patients, NP, 
RN, MA 
• Introduction and 
Ice breaker 
session 
Group room  Each staff introduced him/herself 
and each patient did the same. 
HIPPA reminder was discussed 
during this session 
 NP • Medical 
management   
Group room  NP sequentially attended to each 
patient in the group starting with 
brief medical history first, followed 
by brief physical examination and 
finally, discussion of the lab results 
including hemoglobin A1C and 
medication management with the 
participation of the group as peer 
support. Each patients progress was 
discussed in the group. Peers 
provided support as necessary. This 
lasted 5-10 minutes per patient 
 NP  
RN 
DSME Group room  Presentation using, pictures, 
handouts. Week 3 education was 
focused on diabetes complications 
and medication management. 
American Diabetes Association 
(ADA) professional resource 
handouts on hypoglycemia and 
glucose monitoring. We discussed 
about oral diabetes medications and 
importance of adherence, identifying 
the ones that are insulin sensitizers 
and the ones that can cause 
hypoglycemia. We also discussed 
insulin including self-titration using 
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When-  
Date  
 
Who What Where How  
sliding scale, appropriate injection 
sites, and potential for 
hypoglycemia. Complications 
education will include 
macrovascular complications 
(coronary artery disease, stroke and 
peripheral artery disease) and 
microvascular complications 
(retinopathy, nephropathy and 
neuropathy). This lasted for 60 
minutes 
 NP  
RN 
• Peer support in 
the group  
Group room  Patents asked questions, and they 
were also encouraged to share their 
success stories with their peers in 
the group. Patients who are doing 
well with meeting their glycemic 
goal were praised and were 
encouraged to lead the discussion 
and educate those who are 
struggling with meeting their 
glycemic targets. This lasted for 30 
minutes 
 NP • Visit conclusion 
and goals  
Group room The session ended with each patient 
setting a clear achievable goal as to 
how they plan to improve their 
diabetes management before next 
meeting by writing the goal down 
on a paper. The session was 
adjourned until next week Friday. 
April 13th, 
2018/Week 4 
MA • Patient 
registration  
Receptionist desk  Using EPIC EMR 
 RN • Vital signs 
including 
weight and BP 
Group room Using Welch Allyn Dinnamap 
 NP • Patient chart 
review  
Provider office Going through each patient chart  
 Patients, NP, 
RN, MA 
• Introduction and 
Ice breaker 
session 
Group room Each staff introduced him/herself 
and each patient did the same. 
HIPPA reminder discussed during 
this session 
 NP  • Medical 
management  
Group room  NP sequentially attended to each 
patient in the group starting with 
brief medical history first, followed 
by brief physical examination and 
finally, discussion of the lab results 
including hemoglobin A1C and 
medication management with the 
participation of the group as peer 
support. Each patients progress was 
discussed in the group. Peers 
provided support as necessary. This 
lasted 5-10 minutes per patient 
 NP 
RN 
• DSME Group room Presentation using videos, pictures. 
Week 4 education focused on 
nutrition management and exercise. 
Association (ADA) professional 
resource handouts on nutrition 
management and exercise. We 
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When-  
Date  
 
Who What Where How  
talked about carbohydrate counting, 
nutrition labels, “my food plate”, 
eating out, meal planning, heart 
healthy eating, food substitution, 
low fat diet, and DASH diet. We 
also talked about types of exercise, 
barriers to exercises, adopting an 
exercise regimen, and exercise and 
blood sugar. This lasted for 60 
minutes 
 NP 
RN 
• Peer support in 
the group  
Group room Patents asked questions, and they 
were encouraged to share their 
success stories with their peers in 
the group. Patients who are doing 
well with meeting their glycemic 
goal were praised lead the 
discussion and educate those who 
were struggling with meeting their 
glycemic targets. This lasted for 30 
minutes 
 NP • Visit conclusion 
and goals  
Group room The session ended with each patient 
setting a clear achievable goal as to 
how they plan to improve their 
diabetes management before next 
meeting by writing the goal down 
on a paper. The session was 
adjourned until next 4 weeks 
April 20th,2018/ 
Week 5 
Patients  
NP  
• Individual 
Medical 
Appointment 
(IMA) 
• Patient goals  
• No Shared 
Medical 
Appointment 
(SMA) this 
week  
• Clinic  
 
 
 
• Home  
NP continued with the IMA, and 
also reviewed the process outcomes 
to make sure everything is on target. 
Patients prepared and work on their 
individual goals. NP prepared for 
the booster session and reviewed the 
education materials for that session 
April 30th, 
,2018/ Week 6 
NP  • Project 
milestone  
Provider office  Evaluation of # of patients still 
attending the SMA sessions by 
reviewing the SMA census. 
April 27th, 2018 
/Week 6 
Booster session  
MA  • Patient 
registration  
Receptionist desk  Using EPIP EMR 
 RN • Vital signs 
including 
weight and BP 
Group room  Using Welch Allyn Dinnamap 
 NP • Patient chart 
review  
Provider office  Going through each patient chart  
 Patients, NP, 
RN, MA 
• Introduction and 
Ice breaker 
session 
Group room Each staff introduced him/herself 
and each patient did the same. 
HIPPA reminder discussed during 
this session 
 NP  • Medical 
management  
Group room  NP sequentially attended to each 
patient in the group starting with 
brief medical history first, followed 
by brief physical examination and 
finally, discussion of the lab results 
including hemoglobin A1C and 
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When-  
Date  
 
Who What Where How  
medication management with the 
participation of the group as peer 
support. Each patients progress was 
discussed in the group. Peers 
provided support as necessary. This 
lasted 5-10 minutes per patient 
 RN • DSME Group room Presentation using, pictures, 
handouts. Week 8 education will 
focus on foot care. This education 
was conducted by the clinic RN in 
the group room using American 
Diabetes Association (ADA) 
professional resource handouts on 
diabetic foot care. Proper foot care 
for diabetics, diabetes foot ulcers, 
when to visit podiatrist will be 
discussed.  This lasted for 60 
minutes 
 NP 
RN 
• Peer support in 
the group 
Group room Patents asked questions, and they 
were encouraged to share their 
success stories with their peers in 
the group. Patients who are doing 
well with meeting their glycemic 
goal were praised and lead the 
discussion and educate those who 
were struggling with meeting their 
glycemic targets. This lasted for 30 
minutes 
 NP • Visit conclusion 
and goals  
Group room The session ended with each patient 
setting a clear achievable goal as to 
how they plan to improve their 
diabetes management before next 
meeting by writing the goal down 
on a paper. The session was 
adjourned until next 4 weeks 
May 4th, 2018 
/Week 7 
Patients 
NP  
• IMA 
• Patient goals  
• No SMA this 
week 
• Clinic  
• Home  
NP continued with the IMA and 
reviewed the process outcomes to 
make sure everything is on target. 
Patients prepared and worked on 
their individual goals. 
May11th, 2018/ 
Week 8 
MA • Patient 
registration  
Receptionist desk  Using EPIP EMR 
 RN • Vital signs 
including 
weight and BP 
Group room Using Welch Allyn Dinnamap 
 NP • Patient chart 
review  
Provider office  Going through each patient chart 
 Patients, NP, 
RN, MA 
• Introduction and 
Ice breaker 
session 
Group room  Each staff introduced him/herself 
and each patient did the same. 
HIPPA reminder will be discussed 
during this session 
 NP • Medical 
management  
Group room NP sequentially attend to each 
patient in the group starting with 
brief medical history first, followed 
by brief physical examination and 
finally, discussion of the lab results 
including hemoglobin A1C and 
medication management with the 
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When-  
Date  
 
Who What Where How  
participation of the group as peer 
support. Each patients progress was 
discussed in the group. Peers 
provided support as necessary. This 
lasted 5-10 minutes per patient 
 NP  • DSME Group room Presentation using, pictures, 
handouts. Week 12 education 
focused on behavioral modification. 
NP utilized motivational 
interviewing techniques, and topics 
included readiness to change. This 
lasted for 60 minutes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NP  
RN 
• Peer support in 
the group 
Group room Patents asked questions, and they 
were encouraged to share their 
success stories with their peers in 
the group. Patients who are doing 
well with meeting their glycemic 
goal were praised and lead the 
discussion and educate those who 
might be struggling with meeting 
their glycemic targets. This lasted 
for 30 minutes 
 
 
 
 
 NP • Visit conclusion  Group room The SMA session ended with the 
same knowledge test that was 
administered on the first day of the 
implementation using University of 
Michigan Diabetes Research 
Training Center Diabetes 
Knowledge Test. The results were 
compiled and enter Excel sheet for 
analysis. Each patient set a clear 
achievable long-term goal as to how 
they plan to improve their diabetes 
management by writing the goal 
down on a paper.  
This session will conclude the SMA 
sessions. All the patients were 
thanked for their attendance. 
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Appendix F: Model for Evidence Based Practice Change 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1.   Model for Evidence Based Practice Change 
  
Step 1. Assess the need for 
change in practice. Current 
recommended national guideline 
for A1C is below 7, current 
average A1C in my clinic is 7.6. 
Current recommended BMI is 
below 25kg/m^2, and average 
BMI in my clinic is 32kg/m^2. 
This data lead to formulation of 
the PICOT question 
Step 2. Locate the best evidence. 
Keywords retrieved from the 
PICOT question and systematic 
search conducted using the same 
strategy in the CIHAHL, PubMed 
and Cochrane.   
 
Step 6.  Integrate and maintain 
change in practice. 
Recommendations will be 
presented to the stakeholders. 
Based on the outcomes, standards 
will be integrated into practice 
and results disseminated   
Step 3. Critically analyze the 
evidence. All the studies located 
during the systematic search were 
critically appraised using RCA/GAO 
forms. The following evidences 
were located after the review: 2 level 
I, 5 Level II, 2 level III, 1 level IV, 2 
level VI, and 1 level VII. Synthesis 
table created based on these studies  
Step 4. Design practice change. 
Protocols which will include 
implementation plan will be 
created 
Step 5. Implement and evaluate 
practice change.  Patients will be 
notified and intervention will begin. 
Will evaluate processes, outcomes, 
and cost. Then conclusions and 
recommendations will be outlined.   
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Appendix G: Health Belief Model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 1.2. Health Belief Model  
 
Sociopsychology 
variables (Peer 
support in SMA).  
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(Knowledge gain 
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Perceived benefits of 
preventive action 
(Prevention of 
diabetes 
complications) 
Perceived 
Seriousness 
(severity) of 
disease. 
(Uncontrolled 
diabetes) 
Self-Efficacy 
(Health behavior 
change,  
Reduced Hgb A1C  
Reduced BMI) 
Perceived threat of 
disease. 
(Complications of 
diabetes) 
Cues to action 
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(Shared medical 
Appointment (SMA) 
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Appendix H: Logic Model 
 
Assumptions            Inputs/Resources                Activities                        Outputs                                  Outcomes                                   
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
                
 
 
 
 
 
 
 
 
Figure 1.3. SMA Logic model   
 
• ↑ Diabetes 
knowledge will 
promote 
compliance  
• Many diabetes 
patients will 
choose to attend 
the SMA 
because it will 
benefit them 
• Swift approval of 
the project by 
leadership  
• Office Space 
• Staff  
• DVD player  
• Computer with 
internet 
connection 
• Furniture 
• Teaching models  
• Dinamap  
• A1C Machine  
• Electronic scale  
• Television  
• Pamphlets  
• Data collection 
tools  
• Stethoscope 
• Budget 
• # of SMA visits  
• Diabetes  
education  
• Physical exam 
• Lab review  
• Health history  
• Peer interaction  
• Nutrition 
education 
• Behavior 
modification 
education  
• Vital signs per 
visit 
• Staff training 
• Data analysis  
• Short term goals: Pt 
recognize that uncontrol 
diabetes can lead to 
serious complications  
• Medium term goals: 
More patients will 
attend SMA visits  
• Long term goals:  
• Achieve A1C < 7 
each patient 
• Prevention of 
complications 
• ↑ Medication 
knowledge 
• ↑ Overall diabetes 
knowledge 
• ↑ Exercise levels  
• ↓ BMI 
• Adoption of healthy 
eating  
External Influences: Patient transportation difficulties, DSRIP grant availability, UTSW/Lifepath collaboration   
Legend: ↑=increased; SMA=shared medical appointment; ↓=decreased 
Process Makers:  
• Project protocol 
completion by 
12/2017 
• IRB approval 
letter completed 
by 3/8/2018 
• Team 
meeting/educatio
n/mock SMA 
by1/19/18 
• Baseline data 
collection by 
3/23/2018 
• Post intervention 
data collected by 
5/11/2018 
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Appendix I: Shared Medical Appointment Process Outcomes 
Table I  
   SMA process outcomes with measurements 
 
 
 
 
 
  
Estimated date of completion Process Maker   Measurement  
1/19/18 IRB proposal complete and submit 
for review 
Check Mark 
3/8/18 Final IRB approval for the project Check Mark 
12/15/17 Project Protocol completion Check Mark 
1/19/18 Staff education on protocol Completion rate  
 
3/23/18 
Project Implementation and baseline 
data collection 
A1C-  Query from Epic  
BMI- Query from Epic 
Lipid values- Query from EPic 
BP- Welch Allyn Dinnamap 
Knowledge- Diabetes knowledge 
test 
4/30/18 Project milestone assessment to 
check if datelines are being met 
Check mark 
4/30/18 Number of patients who continue to 
show for SMA sessions 
# of attendance per session  
5/11/18 Final data collection for A1C and 
BMI 
Intake data collection form 
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Appendix J: Diabetes Care Cost 
Table J  
  Average diabetes care cost comparing clinic visit, hospital inpatient and emergency room visit  
 
 
 
 
 
 
 
Values  Diabetes Management Clinic Emergency Room  Inpatient  
Encounters  1096 320 539 
Avg Length of Stay  0.00 0.00 5.21 
Avg of total Charges  $298 $2,682 $27,992 
Avg Reimbursement  $167 $834 $11,144 
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Appendix K: SMA Implementation Budget 
Table K 
   SMA implementation budget  
 
SMA Project Budget
Expenses Quantity Unit Price Total 
Rent per month 3 2,083.00$        6,250.00$            
Utility cost 3 667.00$            2,000.00$            
Dinamap 1 2,600.00$        2,600.00$            
A1C Machine 1 2,740.00$        2,740.00$            
Computers 3 1,500.00$        4,500.00$            
Electronic Scale 1 473.00$            473.00$                
Paper 5 3.72$                 18.60$                  
Monofilament 2 64.14$              128.28$                
Otoscope 1 85.00$              85.00$                  
Stapler 2 27.99$              27.99$                  
Printer Ink 3 31.99$              95.97$                  
Printer/Scanner 1 99.99$              99.99$                  
Microalbumin machine 1 873.75$            873.75$                
Microalbumin Strip 1 98.79$              98.79$                  
Otoscope probe box 1 33.56$              33.56$                  
NP Salary/Hr 22 55.00$              1,210.00$            
RN Salary/Hr 22 33.00$              726.00$                
CMA salary/Hr 22 14.00$              308.00$                
Total 22,268.93$          
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Appendix L: Gantt Chart 
   Table L 
      Gantt showing SMA implementation timeline 
 
 
 
1/19 2/18 3/20 4/19 5/19 6/18 7/18 8/17 9/16 10/16 11/15 12/15 1/14 2/13 3/15 4/14 5/14 6/13 7/13 8/12
Staff education and Mock SMA
IRB Approval
SMA Begins Week 1
SMA Week 2
SMA Week 3
SMA Week 4
SMA Booster session 1
SMA Booster session 2
Data analysis
Dessimination
Sustainability
SMA Implementation Gantt Chart 
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Appendix M: SMA Results 
 
 
 
Figure 1.4.  Pre and post mean outcome SMA intervention values. 
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Figure 1.5. SMA pre and post hemoglobin A1C values 
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Figure 1.6.  A1C Values for Participants who attended >3 SMAs 
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Figure 1.7. Effect of SMA on Patient Outcomes   
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Figure 1.8. Pre and Post Mean A1C 
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Figure 1.9. Percent of patients at A1C goal post SMA intervention 
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Figure 2.0. Percent of patients at blood pressure goal post SMA intervention 
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Table M:  SMA Clinical Outcomes, N=17 
Outcome Measure Pre-Mean Post-Mean p value (paired t-test) 
HbA1c (%) 8.0 7.5 0.139 
Systolic BP (mmHg) 133 126 0.145 
Diastolic BP (mmHg) 81 75 0.043 
LDL (mg/dl) 99 95 0.433 
HDL (mg/dl) 47 48 0.470 
Triglycerides (mg/dl) 221 222 0.985 
Total Cholesterol (mg/dl) 190 183 0.337 
BMI (kg/m2) 35 34 0.139 
